NSG 523 · Med-Surg I · Units 5–10 · Remotely Proctored

HESI
Exam 2 Mastery

Six systems, one cumulative test. The full guide — exam mechanics, all six units, cross-system integration, a 126-card drill deck, and 30 scored applied items with distractor logic.

—days to target
TARGET SIT → SUN · JUL 26, 2026
STUDY WINDOW: TUE JUL 21 – SAT JUL 25
ACCOMMODATION: 200% TIME — run the full chain on every item
EXAM 1 BASELINE: 1062 — the architecture works
Study window—
Day by day

Five days, hour-blocked

Heaviest and least-familiar material first, while capacity is highest and there's still time to patch what breaks. Tick blocks as you finish them — the day you're on is highlighted automatically. Sleep is consolidation, not lost study time.

TUEJul 21

Framework + Unit 7 Cardiovascular

U7 is the largest unit and carries your biggest gap. Front-load it.

0%
  • Part 1 in full — write the priority tree from memory (60m)
  • Part 2 lab panel — write it out cold, circle misses (45m)
  • §7.1 hypertension + §7.2 heart failure — verify, don’t re-learn (60m)
  • §7.3 ACS/MI + §7.4 dysrhythmias — NEW, full attention (75m)
  • §7.5 anticoagulation — drug → lab → antidote, out loud (45m)
  • §7.14 red flags, then stop (20m)
WEDJul 22

Unit 7 Heme + Unit 8 Renal

The AKI/CKD block is the single biggest content gap in your files.

0%
  • Cold recall of Tuesday — patch misses only (30m)
  • §7.7–7.10 anemias, sickle cell, transfusion, platelets/DIC (50m)
  • §7.11–7.13 PAD, vascular, shock table (40m)
  • §8.7 AKI — 3 categories, 4 phases, hyperkalemia sequence (75m)
  • §8.8 CKD + §8.9 dialysis — binders, fistula rules, cloudy effluent (60m)
  • §8.1–8.6 GU review + §8.11 red flags (30m)
THUJul 23

Units 5 & 6 — GI

Your strongest existing material. Verification day plus four gap-fills.

0%
  • §5.1–5.3 IBD, IBD pharm, GERD/Barrett’s — run recall cold (40m)
  • §5.4 IBS/celiac/hernia + §5.5 obesity + §5.6 motility (30m)
  • §6.1–6.5 obstruction, nutrition, gallbladder, PUD, appendicitis (40m)
  • §6.6 pancreatitis + §6.7 cirrhosis — NEW, high-yield (60m)
  • §6.8–6.10 GI bleed, ostomy, colorectal (30m)
  • §4.1 acid–base + §4.2 potassium (30m)
FRIJul 24

Units 9 & 10 — Neuro, Pain, Sensory, Seizure

Most of this unit is new. Two crisis discriminators to make automatic.

0%
  • §9.1 neuro/ICP + §9.2 delirium vs dementia + §9.3–9.4 (45m)
  • §9.5–9.8 MS, myasthenia, Guillain–Barré, ALS — NEW (60m)
  • §9.9 headache + §9.10 pain management (45m)
  • §10.1–10.4 seizures, status epilepticus, AED table (50m)
  • §10.6 visual + §10.7 auditory — entirely new (60m)
  • §9.11 + §10.8 red flags (20m)
SATJul 25

Integration + self-assessment

No new content. Interleaved retrieval beats blocked review.

0%
  • Part 4 in full — build the chains from memory (60m)
  • All 30 applied questions, timed, no notes (75m)
  • Score, then re-derive every miss — both directions (60m)
  • Re-drill your 2–3 weakest sections only (45m)
  • Lab panel + priority tree, cold, one last time (30m)
  • Stop by early evening. Lay everything out. Sleep.
SUN · JUL 26

HESI EXAM 2

  • No new material. No practice questions. No cramming.
  • Twenty minutes maximum: skim the red-flag lists and the lab panel. That's all.
  • Set up ProctorU early so the technology isn't the stressor.
  • Read every stem twice. Predict before you look. Run the priority tree on every "first" item.
  • Unfamiliar item? Fall back to expected-vs-unexpected, then ABC.
Before content

How this exam thinks

The scaffolding that carried Exam 1, plus the two things a six-unit cumulative test adds: cross-system stems, and the expected-vs-unexpected filter that lets you answer correctly on content you don't recognize.

Exam mechanics, priority tree & the cumulative layer

1.1 Scoring reality

HESI scores 0–1500. 850 = acceptable, 900 = recommended. Your gradebook conversion ≈ HESI score × 0.09 (0–99.99 scale) — 1062 converted to roughly 95.6. NGN item types (bow-tie, matrix/trend, drag-and-drop, unfolding case studies) count in the scored total, not as unscored pilots (Evolve RN HESI Implementation Guide, 2024; Nightingale/CliffsNotes HESI results, 2025). HESI is validated as an NCLEX predictor, which is why it weights application over recall (NursingTip, 2025).

1.2 The question formats

  • Standard multiple choice — one best answer. Two or three options are usually true; only one is the priority.
  • SATA — no partial credit. Treat each option as an independent true/false against the fact base. Do not anchor on how many you expect to be correct.
  • Priority / ordering — sequence of actions.
  • NGN — matrix (anticipate/monitor/contraindicated), bow-tie (condition ← actions → parameters), unfolding cases across 4–6 linked items.

Stem vocabulary that signals a priority item: first, initial, priority, most important, immediate, requires immediate intervention, warrants notification, best indicates, would most concern the nurse.

1.3 The priority decision tree — run this on every "first/priority" item

  1. Airway → Breathing → Circulation. An airway or breathing threat beats everything. Silent chest, stridor, RR <10, falling SpO₂, aspiration risk, respiratory muscle weakness (myasthenia, Guillain-Barré) — always wins.
  2. Acute/unstable beats chronic/expected. A new, abnormal, unexpected finding beats a chronic-but-stable one. Lipase 3× normal in known pancreatitis is expected. Carpal spasm in that same patient is new hypocalcemia and dangerous.
  3. Maslow — physiologic before psychosocial.
  4. Safety / imminent harm.
  5. Nursing process — assess before you intervene, unless ABC is actively failing, in which case you act.
  6. Least invasive / least restrictive when options are otherwise equal.

1.4 The cumulative-exam layer [new for Exam 2]

Exam 1 tested four units that shared one substrate (fluids, acid-base, peri-op, respiratory). Exam 2 tests six systems that collide. HESI exploits this three ways:

(a) Cross-system stems. The patient has a renal problem and a cardiac consequence. The question is which one you address. → CKD patient with K⁺ 6.4 and peaked T waves: the answer is cardiac (stabilize the myocardium), not renal.

(b) Same finding, different meaning by system. "New confusion" is delirium from UTI (U8), hepatic encephalopathy (U6), hypoxia (↩U4), hyponatremia from TURP syndrome (U8) or carbamazepine (U10), or digoxin toxicity (U7). The distinguishing detail is always in the stem — find it before you answer.

(c) Drug collisions. One patient, two units, one contraindication. PDE-5 inhibitor + nitrate. ARNI + ACEi. Enzyme-inducing AED + oral contraceptive. Aminoglycoside + loop diuretic (double ototoxicity, ↩U4 + U7).

1.5 The expected-vs-unexpected filter — your highest-leverage heuristic

On a six-unit exam you will not always know the disease cold. You can still get the item right by asking: given this diagnosis, is this finding expected or unexpected?

Diagnosis EXPECTED (do not panic) UNEXPECTED (this is the answer)
Post-op lap chole Referred right shoulder pain (CO₂) Fever + RUQ pain + jaundice
Post-TURP Pink-tinged irrigation return Bright red with clots; ↓Na⁺ + confusion
Ileostomy Liquid output No output + distension + cramping
Cirrhosis Spider angiomas, jaundice Asterixis, hematemesis, cloudy ascitic fluid
Rifampin (↩U4) Orange-red urine Jaundice, RUQ pain
New AV fistula Thrill and bruit Absent thrill; cool/numb hand
Seizure patient Postictal drowsiness ~30 min Seizure ≥5 min; no recovery between
Dialysis session 2–3 kg weight loss Headache, N/V, confusion mid-run (disequilibrium)

1.6 SATA discipline

Read the stem. Judge each option independently. Common HESI SATA architecture: 3 correct, 2 wrong — but never assume. The two most frequent wrong-option flavors: - The plausible-but-contraindicated (antidiarrheal in C. diff; heat on appendicitis; iron in thalassemia; BP cuff on the fistula arm). - The right action at the wrong time (ambulate a patient who is currently hypotensive; teach a patient who is currently in pain).

1.7 The delegation lens — permanent, not a closed unit ↩U1

HESI threads scope-of-practice through every exam. Same rules, new patients:

  • RN only: assessment, teaching, evaluation, clinical judgment, first dose, unstable patient, blood administration verification, initial ostomy/stoma assessment, neuro checks, titration.
  • LPN/LVN: stable patients with expected outcomes, reinforcing teaching, most routine meds, ostomy care on an established stoma, tube feedings on a stable patient, catheter insertion (varies by state).
  • UAP: ADLs, vitals on stable patients, I&O, ambulation, hygiene, positioning, feeding a patient without dysphagia, emptying an ostomy pouch, specimen collection. Data collection, not assessment.

Rule: delegate the stable, routine, predictable. Keep the unstable, novel, judgment-dependent.

1.8 Your 200% time strategy

Double time means the correct approach is not to go faster — it's to run the full chain on every item: 1. Read the stem twice. Identify the actual question (first action? highest priority? which to report?). 2. Name the system(s) in play and the phase of illness. 3. Cover the options. Predict your answer. 4. Uncover. Eliminate by the priority tree, not by feel. 5. On SATA, re-read each option against the stem individually.

Budget: ~2 minutes per standard item, ~4 for NGN cases. You will finish with time left.


The lab panel — Exam 1 carryover + 20 additions

This silently underlies about a third of the exam. Write it out three times before Saturday.

2.1 Carried from Exam 1 ↩

Value Normal HESI red flag
Potassium (K⁺) 3.5–5.0 mEq/L >6.0 = peaked T waves → cardiac arrest. <3.0 = dysrhythmia + digoxin toxicity
Sodium (Na⁺) 135–145 mEq/L <120 or rapid shift = seizure / cerebral edema. Correct slowly (osmotic demyelination)
Calcium (Ca²⁺) 8.5–10.5 mg/dL Low → Trousseau/Chvostek, tetany, laryngospasm, seizure. High → dysrhythmia, stones
Magnesium (Mg²⁺) 1.5–2.5 mEq/L Low → torsades, refractory hypokalemia. High (renal) → ↓reflexes, resp. depression
pH 7.35–7.45 <7.35 acidosis / >7.45 alkalosis
PaCO₂ 35–45 mmHg Respiratory parameter (acid)
HCO₃⁻ 22–26 mEq/L Metabolic parameter (base) — the kidney is the metabolic compensator
PaO₂ 80–100 mmHg <60 = respiratory failure
SpO₂ 95–100% (88–92% CO₂ retainers) Trend > single number

2.2 Added for Exam 2 + NEW

Value Normal Why it matters
BUN 10–20 mg/dL ↑ in renal failure, dehydration, GI bleed, high protein, steroids
Creatinine 0.6–1.2 mg/dL Most specific renal marker. Doubling ≈ 50% GFR loss
BUN:Cr ratio ~10–20:1 >20:1 = prerenal (dehydration, ↓perfusion, GI bleed). ~10–15:1 = intrarenal
eGFR >90 mL/min/1.73m² CKD staging: G3a 45–59 · G3b 30–44 · G4 15–29 · G5 <15 = ESRD
Phosphorus 2.5–4.5 mg/dL ↑ in CKD (inverse of Ca²⁺); ↓ in refeeding syndrome
Troponin I/T <0.04 ng/mL (assay-dependent) Most specific cardiac marker. Rises 3–4 h, peaks 12–24 h, stays 10–14 d
CK-MB 0–3% of total CK Rises 4–6 h, peaks 18 h, returns 48–72 h — useful for re-infarction
BNP <100 pg/mL >100 supports HF; >400 strongly suggestive
Hemoglobin M 14–18 / F 12–16 g/dL <7 typical transfusion threshold in stable patients
Hematocrit M 42–52% / F 37–47% ≈ 3 × Hgb
MCV 80–100 fL <80 microcytic (iron) · >100 macrocytic (B12/folate)
WBC 5,000–10,000/mm³ ANC <500 = severe neutropenia → protective precautions
Platelets 150,000–450,000 <50k trauma bleed · <20k spontaneous · <10k critical
INR 0.8–1.1 (therapeutic 2–3, mechanical valve 2.5–3.5) Warfarin monitoring; ↑ in liver failure
aPTT 30–40 sec (therapeutic 1.5–2.5× control) Heparin monitoring
D-dimer <0.5 mcg/mL Sensitive not specific — rules PE/DVT out; ↑↑ in DIC
Ammonia 15–45 mcg/dL ↑ in hepatic encephalopathy
Albumin 3.5–5.0 g/dL ↓ in liver failure, malnutrition, nephrotic syndrome
Total bilirubin 0.3–1.0 mg/dL ↑ → jaundice (visible ~2–3 mg/dL)
AST / ALT AST 10–40 · ALT 7–56 U/L AST:ALT >2:1 suggests alcohol-related liver disease
Amylase 30–110 U/L ↑ pancreatitis (less specific)
Lipase 0–160 U/L More specific for pancreatitis; 3× ULN is diagnostic
Digoxin 0.5–2.0 ng/mL (HF target 0.5–0.9) Narrow index. Hypokalemia potentiates toxicity
Phenytoin 10–20 mcg/mL Narrow index. Nystagmus → ataxia → confusion as it climbs
Carbamazepine 4–12 mcg/mL Watch Na⁺ and CBC
Valproate 50–100 mcg/mL Watch LFTs, ammonia, platelets
Urine specific gravity 1.005–1.030 ↑ concentrated (dehydration, SIADH) · ↓ dilute (DI, renal failure)
PSA <4 ng/mL Draw before DRE; ↑ with BPH, prostatitis, cancer
Serum osmolality 275–295 mOsm/kg Pairs with Na⁺ for the hypo/hypernatremia picture

Two numbers to hold above all others on this exam: K⁺ 6.0+ with ECG changes, and Na⁺ under 120. They cross four of your six units and they are almost always the answer to "which finding requires immediate intervention."


The content

Six units, in full

Your existing tables preserved. The counter on each unit shows how many blueprint additions and red flags it contains — + NEW marks content that wasn't in your working files, so you can skip anything your syllabus excludes.

U5 GI I — Chronic & FunctionalFrame: inflammation vs motility 1+ · 2🚩

Through-line: the gut is a tube with two failure modes — inflammation and motility. Every U5 topic is one or the other. Anchor: your 26-year-old woman with Crohn's mid-flare.

5.1 IBD — Crohn's vs UC

Crohn's Ulcerative Colitis
Pattern / depth Skip lesions, transmural, mouth→anus Continuous, mucosa only, colon + rectum
Stool Often non-bloody, steatorrhea Bloody / mucoid (hallmark)
Complications Fistulas, strictures, abscess, obstruction, B12 malabsorption Toxic megacolon, perforation, ↑colon cancer
Surgery Not curative (recurs at anastomosis) Curative (colectomy)

Why the table works: transmural → tunnels → fistulas/strictures. Mucosa-only → surface bleeding → bloody stool. Confined to colon → remove colon → cured.

↩ Flare cross-link: profuse diarrhea → loses bicarbonate-rich fluid + K⁺ → hypovolemia + hypokalemia + metabolic ACIDOSIS. Priority assessment is fluid/electrolyte status. Crohn's → B12 deficiency because the terminal ileum (B12's only absorption site) is the most common Crohn's location.

🚩 TOXIC MEGACOLON — UC patient with a rigid, distended, silent abdomen + fever + tachycardia. → Stop antidiarrheals, NPO, NG decompression, notify surgeon. Perforation is imminent. A silent abdomen after hyperactive sounds is always ominous.

5.2 IBD pharmacology

Class Drugs Pearl
5-ASA Sulfasalazine, mesalamine Works in UC, NOT Crohn's. Folic acid supplement, push fluids, sulfa allergy caution
Corticosteroids Prednisone, budesonide Flares only — not maintenance. Taper, never stop abruptly. Hyperglycemia, infection, osteoporosis
Immunomodulators Azathioprine, 6-MP, methotrexate Steroid-sparing; slow onset (weeks–months); monitor CBC + LFTs. MTX teratogenic
Biologics Infliximab, adalimumab, vedolizumab, ustekinumab Screen TB + hepatitis B before starting ↩U4. Infection + malignancy risk; infusion reactions

Surgery: UC → total colectomy is curative (ileostomy or J-pouch). Crohn's → palliative and bowel-sparing (repeated resections → short-bowel syndrome).

5.3 GERD & Barrett's esophagus

GERD = symptomatic reflux. Barrett's = chronic-GERD-induced intestinal metaplasia = premalignant (→ esophageal adenocarcinoma), usually asymptomatic, diagnosed by endoscopy + biopsy with surveillance.

Alarm features → endoscopy now: dysphagia, odynophagia, unintentional weight loss, GI bleeding/anemia, persistent vomiting. Teaching: HOB elevated 6–8 inches (blocks, not just pillows), no recumbency for 2–3 h after meals, smaller meals, weight loss, smoking cessation, avoid triggers (caffeine, chocolate, peppermint, alcohol, fatty/spicy). Aspiration is the safety risk — this is why positioning is a priority, not comfort.

Class Drugs Pearl
Antacids CaCO₃, aluminum/magnesium hydroxide Neutralize existing acid. Aluminum → constipation; magnesium → diarrhea. Separate from other drugs by 1–2 h
H2RAs Famotidine ↓acid secretion; moderate effect; onset faster than PPI
PPIs Omeprazole, pantoprazole, esomeprazole Most effective. Take 30–60 min BEFORE the first meal. Full effect 1–4 days. Standard for Barrett's. Long-term: ↓B12/Mg/Ca, fracture, C. diff risk
Prokinetic Metoclopramide ↑gastric emptying + LES tone. Boxed warning: tardive dyskinesia — limit to ≤12 weeks

5.4 + NEW Gastritis, hiatal hernia, IBS, celiac

  • Acute gastritis: NSAIDs, alcohol, stress, H. pylori. Epigastric pain, N/V, possible hematemesis. Remove the cause + acid suppression.
  • Hiatal hernia: sliding (95%, reflux symptoms) vs paraesophageal/rolling (risk of strangulation — sudden severe pain, dysphagia = emergency). Same lifestyle management as GERD; surgical repair (Nissen fundoplication) for refractory disease — post-op teach no straws, no carbonation, no gas-forming foods (can't belch) and report persistent dysphagia.
  • IBS: functional — normal labs, normal endoscopy. Diagnosis of exclusion (Rome criteria). Subtypes IBS-C, IBS-D, IBS-M. Management: low-FODMAP trial, soluble fiber, stress reduction, antispasmodics, loperamide (IBS-D), linaclotide/lubiprostone (IBS-C), TCAs/SSRIs. Key nursing point: validate the symptoms — "functional" does not mean fabricated.
  • Celiac disease: autoimmune reaction to gluten → villous atrophy → malabsorption. Steatorrhea, weight loss, anemia (iron/folate/B12), osteoporosis, dermatitis herpetiformis. Serology (tTG-IgA) must be drawn while still eating gluten; confirm with biopsy. Treatment is lifelong strict gluten-free diet — wheat, rye, barley out; rice, corn, quinoa, oats (certified) in. Hidden gluten: sauces, soups, beer, medication fillers.

5.5 Obesity — weight-inclusive frame

Chronic, relapsing metabolic disease with strong genetic and environmental determinants — not a willpower deficit. Weight stigma in healthcare independently worsens outcomes by delaying care-seeking and shifting diagnostic attention away from the presenting complaint.

BMI: overweight 25–29.9 · Class I 30–34.9 · Class II 35–39.9 · Class III ≥40. Pair with waist circumference; BMI misclassifies at the individual level. Comorbidities: T2DM, HTN, dyslipidemia, CAD, HF, OSA, MASLD, OA, GERD, obstetric risk, several cancers.

Class Drug Pearl
Noradrenergic anorexiant Phentermine Appetite suppression; ↑HR/BP, insomnia; contraindicated in CVD, short-term
Lipase inhibitor Orlistat Blocks fat absorption; oily stools, flatus, fat-soluble vitamin (A/D/E/K) malabsorption — supplement at a separate time
Combination Naltrexone–bupropion Central; monitor BP, mood, seizure threshold
Incretin (current standard) Semaglutide, tirzepatide ~15–22% weight loss + cardiovascular/renal benefit. GI effects (N/V, constipation), pancreatitis caution, boxed warning: medullary thyroid carcinoma/MEN2, gastroparesis — hold before anesthesia

Bariatric surgery (BMI ≥40, or ≥35 with comorbidity): Roux-en-Y (restrictive + malabsorptive → dumping syndrome, B12/iron/calcium/thiamine deficiency), sleeve gastrectomy (most common), adjustable band, BPD/DS. Post-op priorities: ① airway (OSA is common — HOB up, CPAP), ② VTE prophylaxis + early ambulation, ③ anastomotic leak — tachycardia, fever, abdominal or left shoulder pain, restlessness = emergency, ④ staged diet advancement, ⑤ small frequent meals, no fluids with meals (30 min before/after), ⑥ dumping syndrome teaching (avoid simple sugars; lie down after eating), ⑦ lifelong vitamin supplementation.

5.6 Motility — constipation and diarrhea

Constipation: slowed transit. Causes: low fiber/fluid, immobility, opioids (tolerance never develops — prophylax), anticholinergics, iron, hypothyroidism, hypercalcemia, hypokalemia. Complications: fecal impaction (paradoxical liquid stool leaking around the mass — do not treat as diarrhea), obstruction. Any patient started on opioids gets a prophylactic stimulant laxative. Stool softener alone is insufficient.

Diarrhea: ↩ priority complication = dehydration + hypokalemia + metabolic acidosis. 🚩 Red flag combination: bloody diarrhea + fever + recent antibiotics = C. difficile. - NO antimotility agents — retaining toxin precipitates toxic megacolon. - Soap-and-water hand hygiene — alcohol gel does not kill spores. - Contact precautions, dedicated equipment, bleach-based cleaning. - Treatment: oral vancomycin or fidaxomicin (metronidazole is now second-line); fecal microbiota transplant for recurrence.

Class Drug Pearl
Bulk-forming Psyllium, methylcellulose Safest, first-line. Requires adequate fluid or it worsens obstruction. Slow onset
Stimulant Bisacodyl, senna Fast; standard for opioid-induced constipation
Osmotic PEG, lactulose, magnesium citrate Lactulose also treats hepatic encephalopathy (traps ammonia)
Softener / lubricant Docusate; mineral oil Mineral oil → ↓fat-soluble vitamins, aspiration risk — never at bedtime
Antidiarrheal Loperamide, diphenoxylate–atropine NEVER in infectious diarrhea or C. diff

5.7 Unit 5 red flags

  • Rigid, distended, silent abdomen + fever in UC → toxic megacolon
  • Bloody diarrhea + recent antibiotics → C. diff, no antimotility, soap and water
  • Dysphagia / weight loss / GI bleed in a GERD patient → endoscopy, not reassurance
  • Post-bariatric tachycardia + fever + shoulder pain → anastomotic leak
  • Watery stool in a constipated immobile patient → impaction, not diarrhea
U6 GI II — Acute & SurgicalFrame: perforation → peritonitis → sepsis 5+ · 7🚩

Through-line: the acute abdomen races obstruction/inflammation → ischemia → perforation → peritonitis → sepsis. Every U6 topic occupies a point on that line. Your job is to name the stage. Anchor: your 68-year-old post-op adhesion SBO.

6.1 Intestinal obstruction — SBO vs LBO

SBO LBO
Onset Rapid Gradual
Vomiting Early, profuse (often bilious/feculent) Late or absent
Distension Moderate Marked
Constipation/obstipation Later Early
#1 cause Adhesions (hernia #2) Colorectal cancer (volvulus, diverticular stricture)

Four cardinal symptoms: pain, vomiting, distension, obstipation. Bowel sounds: high-pitched/hyperactive early → absent late. Absent is worse. Simple vs strangulated: strangulation = blood supply lost = fever, tachycardia, leukocytosis, ↑lactate, peritoneal signs, constant (not colicky) pain → surgical emergency. CT with contrast = gold standard. Management: NPO, NG decompression, IV fluid + electrolyte replacement (the priority), analgesia, surgery if complete or strangulated.

↩ NG suction → metabolic ALKALOSIS + hypokalemia + hypochloremia — loses acid from above. The mirror image of diarrhea's acidosis. This contrast is a near-guaranteed item.

6.2 Nutrition support

"If the gut works, use it." Enteral is preferred — maintains mucosal integrity, fewer infections, cheaper.

  • G-tube = stomach → bolus, intermittent, or continuous.
  • J-tube = jejunum, bypasses the stomach → continuous only (jejunum has no reservoir capacity; bolus causes dumping). Used when aspiration risk is high or the stomach must be bypassed.
  • Placement verification: X-ray is the only reliable initial check. Auscultating an air bolus is not acceptable. Ongoing: pH of aspirate + measured external tube length.
  • HOB 30–45° during and for 30–60 min after feeding.
  • Flush with water before/after feeds and before/after every medication. Never crush enteric-coated or extended-release forms.
  • Check residuals per policy; holding for high residual alone is no longer routine — assess the whole picture.

TPN safety: central line required (hypertonic); dedicated line — no piggybacking; monitor glucose q4–6h; strict aseptic technique; daily weights and electrolytes; never stop abruptly → hang D10W if the next bag is unavailable (rebound hypoglycemia).

🚩 REFEEDING SYNDROME: in a chronically malnourished patient, reintroducing carbohydrate drives phosphorus, potassium, and magnesium into cells → cardiac arrhythmia, respiratory failure, death. Start slow, advance slowly, replete electrolytes before and during, monitor daily. Highest-risk: anorexia nervosa, alcohol use disorder, prolonged NPO, post-bariatric.

6.3 Gallbladder disease

Cholelithiasis = stones. Cholecystitis = inflammation, usually obstructive. Classic risk profile: female, forties, fertile, higher body weight, fair — plus rapid weight loss, pregnancy, oral contraceptives, Native American and Hispanic ancestry. Presentation: RUQ pain radiating to the right shoulder/scapula, worse after fatty meals, N/V, fever. Murphy's sign (inspiratory arrest on RUQ palpation) = cholecystitis. RUQ ultrasound = test of choice. Laparoscopic cholecystectomy = gold standard. Post-op: referred shoulder pain from residual CO₂ is expected — ambulate, position; report fever, jaundice, clay stools, dark urine. Choledocholithiasis/cholangitis: stone in the common bile duct → Charcot's triad (RUQ pain, fever, jaundice) → ERCP. Add hypotension + confusion = Reynolds' pentad = emergency.

6.4 Peptic ulcer disease

Mucosal erosion through the muscularis mucosae. Two causes: H. pylori (#1) and NSAIDs. Spicy food and stress aggravate symptoms; they do not cause ulcers.

Gastric ulcer Duodenal ulcer
Pain timing 30–60 min after eating; food worsens 2–3 h after eating / empty stomach; food relieves; nocturnal
Weight Often loss (avoids eating) Often stable or gain
Malignancy risk Higher — biopsy Rare

Complications: hemorrhage (hematemesis, coffee-ground emesis, melena), perforation (sudden severe pain, board-like rigid abdomen → peritonitis), gastric outlet obstruction. EGD = definitive diagnosis.

⚠ H. pylori regimens — know both: - The regimen your course materials teach (and HESI likely tests): clarithromycin triple therapy — PPI + clarithromycin + amoxicillin × 14 days. - The current standard of care: the 2024 ACG guideline removed clarithromycin triple therapy as a first-line option for treatment-naïve patients because of rising clarithromycin resistance, and preferred optimized bismuth quadruple therapy — PPI + bismuth + tetracycline + metronidazole × 14 days. Rifabutin triple therapy and potassium-competitive acid blocker (vonoprazan) dual therapy are the recommended empiric alternatives in patients without penicillin allergy. - Exam strategy: if the answer choices contain triple therapy and not quadruple, choose triple. If both appear, choose bismuth quadruple. Confirm eradication after treatment either way.

Other PUD drugs: sucralfate (forms a protective barrier — give on an empty stomach, separate from other drugs by 2 h); misoprostol (NSAID-ulcer prophylaxis — contraindicated in pregnancy, causes uterine contractions).

6.5 Appendicitis · Peritonitis · Diverticular disease

Appendicitis: periumbilical pain migrating to RLQ at McBurney's point. Rebound tenderness, Rovsing's (LLQ palpation → RLQ pain), psoas and obturator signs, anorexia (nearly universal), low-grade fever, ↑WBC with left shift. 🚩 Sudden relief of pain = RUPTURE, not improvement. Expect rebound, rigidity, and rising fever next. The three DON'Ts: no heat, no laxatives, no enemas — all increase perforation risk. Withholding analgesia is outdated; pain control does not obscure the diagnosis.

Peritonitis (the shared endpoint): rigid, board-like abdomen, diffuse pain, rebound, absent bowel sounds, fever, tachycardia, hypotension, shallow rapid breathing. The patient lies motionless with knees flexed — colic patients writhe. That posture difference is a HESI discriminator. Emergency management: NPO, NG decompression, aggressive IV fluid resuscitation, broad-spectrum IV antibiotics, surgical source control, semi-Fowler's to localize drainage.

Diverticular disease: diverticulosis = asymptomatic outpouchings (low-fiber, Western diet). Diverticulitis = inflamed/microperforated → LLQ pain, fever, ↑WBC, altered bowels. CT is diagnostic; colonoscopy is contraindicated during acute inflammation (perforation risk) — do it 6–8 weeks after resolution. The diet reversal HESI loves: high-fiber to PREVENT, low-fiber/bowel rest during a FLARE. The old nuts-and-seeds restriction is not evidence-based.

Shared antibiotic theme for intra-abdominal infection: gram-negative + anaerobe coverage — metronidazole + a fluoroquinolone or ceftriaxone; piperacillin–tazobactam for severe disease.

6.6 + NEW Acute pancreatitis

Autodigestion of the pancreas by prematurely activated enzymes. Two causes account for ~80%: gallstones and alcohol. Also hypertriglyceridemia, post-ERCP, hypercalcemia, drugs (thiazides, valproate, GLP-1 agonists), trauma.

Presentation: severe, constant epigastric pain radiating straight through to the back, relieved by leaning forward or curling into a fetal position — the opposite of peritonitis' motionless supine posture. Nausea/vomiting, fever, tachycardia, hypoactive bowel sounds. 🚩 Cullen's sign (periumbilical ecchymosis) and Grey Turner's sign (flank ecchymosis) indicate hemorrhagic pancreatitis — grave prognosis.

Labs: lipase (more specific) and amylase elevated ≥3× upper limit of normal; ↑WBC, ↑glucose, ↑bilirubin, ↓calcium (fat saponification → watch for Chvostek/Trousseau ↩), ↑triglycerides, ↓Hct if hemorrhagic.

Management: 1. Aggressive IV fluid resuscitation — lactated Ringer's preferred; this is the single highest-impact intervention. 2. Pain control — opioids; the old "avoid morphine because of sphincter of Oddi spasm" teaching is not evidence-based. 3. NPO initially, then early enteral feeding (within 24–72 h) — enteral is now preferred over TPN when tolerated. 4. NG suction only for ileus or intractable vomiting. 5. Monitor for hypocalcemia, hyperglycemia, hypovolemic shock, ARDS ↩U4, pseudocyst, necrosis, and multi-organ failure. 6. Position: side-lying with knees flexed, or upright leaning forward.

Chronic pancreatitis: steatorrhea, weight loss, malabsorption, secondary diabetes. Pancreatic enzyme replacement WITH every meal and snack, fat-soluble vitamins, absolute alcohol cessation, smoking cessation.

6.7 + NEW Cirrhosis, portal hypertension, and their emergencies

Causes: alcohol-related liver disease, MASLD (metabolic dysfunction–associated steatotic liver disease, formerly NAFLD), chronic hepatitis B/C.

Portal hypertension produces the whole picture: esophageal/gastric varices, splenomegaly (→ thrombocytopenia), ascites, caput medusae, hemorrhoids. Other findings: jaundice, pruritus, spider angiomas, palmar erythema, gynecomastia/testicular atrophy, fetor hepaticus, clubbing. Labs: ↑bilirubin, ↑AST/ALT (AST:ALT >2:1 suggests alcohol), ↓albumin (→ edema/ascites), ↑INR (↓clotting factor synthesis), ↑ammonia, ↓platelets, ↓Na⁺ (dilutional).

🚩 Bleeding esophageal varices — the U6 cardiac-arrest-equivalent. Massive hematemesis, hypotension, tachycardia. Priority: ABC first — airway protection against aspiration, two large-bore IVs, type and cross, volume + blood, octreotide infusion, IV antibiotics (prophylaxis reduces mortality), endoscopic band ligation, balloon tamponade as a bridge, TIPS for refractory bleeding. Prevention: non-selective beta-blocker (propranolol/nadolol), avoid straining/Valsalva/NSAIDs/alcohol, no rough foods.

Ascites: sodium restriction, spironolactone + furosemide, daily weights and abdominal girth, paracentesis — have the patient void immediately before, position upright, monitor for hypotension after large-volume removal, give albumin with >5 L removal. 🚩 Spontaneous bacterial peritonitis: fever, abdominal pain, or new confusion alone in a patient with ascites → diagnostic paracentesis (PMN >250 cells/mm³) → antibiotics. Low threshold to suspect.

🚩 Hepatic encephalopathy: ↑ammonia → asterixis (flapping tremor), personality change, confusion, day-night reversal → coma. Lactulose titrated to 2–3 soft stools per day — do not hold it because the patient is having stools; that is the therapy. Add rifaximin for recurrence. Identify precipitants: GI bleed, infection, constipation, dehydration, hypokalemia, sedatives. Protein is no longer restricted — malnutrition worsens outcomes.

Bleeding precautions throughout: soft toothbrush, electric razor, no IM injections, avoid NSAIDs/aspirin, monitor for occult bleeding.

6.8 + NEW Acute GI bleeding

Upper GI bleed (above ligament of Treitz) Lower GI bleed
Presentation Hematemesis, coffee-ground emesis, melena (black, tarry) Hematochezia (bright red per rectum)
Causes PUD, varices, Mallory–Weiss tear, gastritis, malignancy Diverticular, angiodysplasia, hemorrhoids, IBD, cancer
Lab clue ↑BUN (digested blood protein) with normal creatinine BUN typically normal

Priority sequence: ABC → hemodynamic assessment (tachycardia and narrowing pulse pressure precede hypotension) → two large-bore IVs → type and cross → isotonic fluid then blood → NPO → IV PPI infusion → octreotide if varices suspected → EGD/colonoscopy. ↩ Shock Index (HR ÷ SBP): ≥0.9 refer, ≥1.4 urgent — catches the compensating patient before the blood pressure falls.

6.9 + NEW Ostomy care

Ileostomy Colostomy
Output Liquid to pasty, continuous Semi-formed to formed by location (ascending liquid → sigmoid formed)
Risks Dehydration + electrolyte loss; enzyme-rich effluent excoriates skin Constipation; odor/gas
Notes No laxatives; chew thoroughly (obstruction risk from high-fiber foods) Sigmoid colostomy may be irrigated for regulation

🚩 Stoma assessment (RN, not delegated on initial assessment): - Pink to beefy red, moist = healthy. Slight bleeding when cleaned is normal. - Pale = anemia or poor perfusion. - Dusky, purple, or black = ischemia/necrosis = notify the surgeon immediately. - Expect mild edema for the first several days.

Appliance: cut the barrier ~1/8 inch larger than the stoma; empty the pouch at one-third to one-half full; change every 3–7 days or if leaking; skin barrier powder/paste for excoriation. Report no output plus distension and cramping (obstruction).

6.10 + NEW Hernias and colorectal cancer

  • Hernia: reducible → irreducible/incarcerated → strangulated (compromised blood supply: severe pain, absent bowel sounds, fever, tachycardia = surgical emergency). Post-herniorrhaphy: avoid lifting/straining, support the incision when coughing, watch for scrotal swelling and urinary retention.
  • Colorectal cancer: screening from age 45 (colonoscopy q10y, FIT annually, others). Right-sided → occult bleeding, iron-deficiency anemia, vague pain. Left-sided → change in bowel habits, narrowed stool, obstruction (the #1 cause of LBO). Any adult with new iron-deficiency anemia needs a colon evaluation.

6.11 Unit 6 red flags

  • Sudden relief of appendicitis pain → rupture
  • Board-like rigid abdomen, patient lies motionless → peritonitis
  • Absent bowel sounds after a period of hyperactive → strangulation/ischemia
  • Hematemesis in a cirrhotic → variceal hemorrhage; airway first
  • Asterixis + confusion in a cirrhotic → hepatic encephalopathy; give the lactulose
  • New confusion in a patient with ascites → SBP until proven otherwise
  • Dusky or black stoma → notify surgeon now
  • Flank or periumbilical ecchymosis in pancreatitis → hemorrhagic; grave
  • Chvostek/Trousseau in pancreatitis → hypocalcemia ↩
U7 Cardiovascular & HematologyFrame: the plumbing vs the fluid inside 10+ · 12🚩

Through-line: the plumbing (HTN, HF, PAD, ACS, dysrhythmias) versus the fluid inside it (anemias, platelets, coagulation). Efficiency note: ACEi/ARB, beta-blockers, and diuretics appear in HTN and HF and CKD. Learn them once in 7.1 and reuse them three times. Anchors: your HTN→HF trajectory patient, the menorrhagia-anemia patient, the diabetic-smoker with PAD.

7.1 Hypertension + the master antihypertensive table

BP = cardiac output × systemic vascular resistance; RAAS is the long-term regulator. "The silent killer."

Categories (2025 AHA/ACC, unchanged from 2017): Normal <120/<80 · Elevated 120–129/<80 · Stage 1 130–139 or 80–89 · Stage 2 ≥140 or ≥90. Universal treatment goal: <130/80. + NEW 2025 guideline updates worth 60 seconds: the PREVENT risk calculator replaces the Pooled Cohort Equations and drives the treat-or-wait decision in stage 1; first-line agent selection is now race-neutral; stage 2 starts on two agents in a single-pill combination; an MRA is added for resistant hypertension; and hypertensive emergency goes to the ICU. First-line classes remain thiazide, dihydropyridine CCB, and ACEi/ARB.

Crisis: urgency (>180/120, no target-organ damage → oral agents, outpatient) vs emergency (>180/120 with organ damage: encephalopathy, stroke, MI, aortic dissection, AKI, papilledema, eclampsia → IV nicardipine, labetalol, clevidipine, nitroprusside). 🚩 The rule: lower MAP by no more than ~25% in the first hour. Faster drops cause watershed stroke, MI, and renal infarction. (Exception: aortic dissection — lower fast and hard.)

Class Mechanism Signature effects / nursing
ACEi (-pril) Blocks angiotensin I→II Dry cough, angioedema, hyperkalemia, teratogenic, ↑Cr acutely (acceptable up to ~30%)
ARB (-sartan) Blocks AT-II receptor No cough; hyperkalemia, teratogenic. Never combine with an ACEi
CCB, dihydropyridine (-dipine) Arterial vasodilation Peripheral edema, headache, reflex tachycardia, gingival hyperplasia
CCB, non-DHP (verapamil, diltiazem) ↓HR + contractility Bradycardia, constipation, heart block; avoid combining with a beta-blocker
Thiazide (HCTZ, chlorthalidone) ↓Na⁺ reabsorption, distal tubule Hypokalemia, hyperglycemia, hyperuricemia (gout), hypercalcemia, photosensitivity
Loop (furosemide, bumetanide) ↓Na⁺ reabsorption, loop of Henle Hypokalemia, ototoxicity (worse with aminoglycosides ↩U4), hypovolemia, hypomagnesemia
K⁺-sparing / MRA (spironolactone, eplerenone) Blocks aldosterone Hyperkalemia, gynecomastia (spironolactone), survival benefit in HF
Beta-blocker (-olol) ↓HR, ↓renin Masks hypoglycemia, bronchospasm (non-selective), fatigue; hold if HR <60; never stop abruptly (rebound tachycardia/ischemia)
Central alpha-2 agonist (clonidine) ↓sympathetic outflow Rebound hypertension if stopped abruptly; sedation, dry mouth
Alpha-1 blocker (-osin) Peripheral vasodilation First-dose syncope — give at bedtime; also treats BPH →U8
Direct vasodilator (hydralazine, minoxidil) Arterial relaxation Reflex tachycardia, fluid retention, lupus-like syndrome (hydralazine)

7.2 Heart failure

HFrEF (EF ≤40%, systolic — problem pumping) vs HFpEF (EF ≥50%, diastolic — problem filling). Mildly reduced 41–49%.

LEFT = Lungs. Dyspnea, orthopnea, paroxysmal nocturnal dyspnea, crackles, pink frothy sputum, S3, fatigue, nocturia. RIGHT = Rest of body. JVD, dependent edema, hepatomegaly, ascites, weight gain, anorexia/nausea from gut congestion. Left failure is the most common cause of right failure.

BNP >100 supports HF; >400 strongly suggestive. ↩ Hypervolemia from Exam 1 is the same assessment. Daily weights at the same time, same clothes, after voiding — report a gain of 2–3 lb in a day or ~5 lb in a week. This is the single most-tested HF teaching point.

🚩 Acute decompensation / flash pulmonary edema: severe dyspnea, orthopnea, pink frothy sputum, anxiety, crackles throughout. Priority: high Fowler's with legs dependent → oxygen → IV loop diuretic → nitrates → morphine (selective) → consider noninvasive ventilation. Airway and oxygenation before pharmacology.

Drug Pearl
ARNI (sacubitril–valsartan) Cornerstone; the 2024 ACC pathway now prefers it over an ACEi/ARB rather than treating them as equivalent. Never with an ACEi — 36-hour washout (angioedema). Hyperkalemia, hypotension
Digoxin 0.5–2.0 ng/mL (HF target 0.5–0.9). Hold if apical HR <60 (count a full minute). Hypokalemia potentiates toxicity. Toxicity: anorexia, N/V, visual halos/yellow-green vision, bradycardia, dysrhythmias. Antidote digoxin immune Fab. Symptom benefit only — no mortality benefit
SGLT2 inhibitor (dapagliflozin, empagliflozin) Mortality benefit even in non-diabetics; genital mycotic infection, euglycemic DKA, volume depletion
MRA (spironolactone, eplerenone) Survival benefit; hyperkalemia — monitor K⁺ and creatinine
Nesiritide IV BNP analog for acute decompensated HF
Milrinone / dobutamine IV inotropes for advanced/low-output HF
Ivabradine SA-node modulator; for sinus rhythm with HR ≥70 despite maximal beta-blocker
Hydralazine + isosorbide dinitrate Survival benefit, particularly in Black patients with HFrEF (per the 2022 AHA/ACC/HFSA guideline)

The four pillars of HFrEF — ARNI/ACEi/ARB + beta-blocker + MRA + SGLT2 inhibitor — and the current emphasis is on getting all four started rapidly rather than sequentially maximizing one at a time.

Teaching: daily weights, sodium restriction (2–3 g), fluid restriction if hyponatremic, energy conservation, report weight gain/increasing edema/worsening dyspnea/orthopnea before it becomes an admission, annual influenza and pneumococcal vaccination ↩U4.

7.3 + NEW Acute coronary syndrome

The spectrum:

Trigger ECG Troponin
Stable angina Predictable exertion; relieved by rest or nitroglycerin ST depression during pain only Normal
Unstable angina At rest, new, or increasing ST depression / T inversion Normal
NSTEMI Rest ST depression / T inversion Elevated
STEMI Rest ST elevation Elevated
Prinzmetal/vasospastic Coronary spasm, often at rest/night Transient ST elevation Usually normal

Classic presentation: crushing substernal chest pressure radiating to the left arm, jaw, or back; diaphoresis; nausea; dyspnea; sense of impending doom. 🚩 The atypical presentation HESI loves — women, older adults, and people with diabetes may present with NO chest pain: fatigue, dyspnea, indigestion, jaw/back/epigastric discomfort, nausea, or syncope. Autonomic neuropathy blunts the pain signal. Do not dismiss a diabetic woman with "indigestion."

Markers: troponin I/T is the most specific — rises 3–4 h, peaks 12–24 h, remains elevated 10–14 days. High-sensitivity assays detect earlier. CK-MB rises 4–6 h, peaks 18 h, normalizes 48–72 h — its value now is detecting re-infarction. Myoglobin rises first but is nonspecific.

Immediate management: 1. 12-lead ECG within 10 minutes of arrival/symptom report. 2. Aspirin 162–325 mg chewed — chewed, not swallowed whole, for rapid absorption. This is often the first pharmacologic action. 3. Oxygen only if SpO₂ <90% — routine oxygen in a normoxic patient is no longer recommended and may cause harm. 4. Nitroglycerin sublingual q5min ×3. Absolute contraindication: a PDE-5 inhibitor (sildenafil/tadalafil) in the preceding 24–48 h → catastrophic hypotension →U8. Also avoid in right-ventricular/inferior MI with hypotension (preload-dependent) and with SBP <90. 5. Morphine for refractory pain — may mask symptoms and is now a lower-tier recommendation. 6. Continuous cardiac monitoring, IV access, serial troponins.

Reperfusion: PCI is preferred — door-to-balloon ≤90 minutes (≤120 if transfer required). Fibrinolysis door-to-needle ≤30 minutes where PCI is unavailable; screen hard for bleeding contraindications (recent surgery, stroke, active bleeding, uncontrolled HTN). Ongoing: dual antiplatelet therapy (aspirin + clopidogrel/ticagrelor/prasugrel), high-intensity statin, beta-blocker, ACEi/ARB, cardiac rehabilitation.

🚩 Post-MI complications: dysrhythmias are the leading cause of death in the first hours; also cardiogenic shock, heart failure, papillary muscle rupture (new holosystolic murmur + acute pulmonary edema), ventricular free-wall rupture, pericarditis and Dressler's syndrome (weeks later).

Teaching: nitroglycerin storage (dark glass, replace q6 months, expect headache/tingling), call EMS if pain persists after the first dose rather than waiting for three, sexual activity generally safe when able to climb two flights of stairs — but never combine nitrates with a PDE-5 inhibitor.

7.4 + NEW Dysrhythmias

Atrial fibrillation — irregularly irregular rhythm, no discernible P waves, variable ventricular response. Loss of atrial kick → ~20% drop in cardiac output. The lethal risk is atrial thrombus → embolic stroke. - Rate control: beta-blocker, non-DHP CCB, digoxin. - Rhythm control: amiodarone, flecainide, cardioversion, ablation. - Anticoagulation stratified by CHA₂DS₂-VASc (CHF, HTN, Age ≥75 = 2, Diabetes, Stroke/TIA = 2, Vascular disease, Age 65–74, Sex category female). - If AF has lasted >48 h or is of unknown duration: 3 weeks of anticoagulation before cardioversion, or a TEE to exclude thrombus first — cardioverting a clot into circulation causes stroke.

SVT — narrow complex, rate 150–250. Vagal maneuvers → adenosine rapid IV push with immediate flush (warn the patient about a brief asystolic pause and chest discomfort) → synchronized cardioversion if unstable.

Ventricular tachycardia — wide complex. With a pulse and stable: amiodarone. With a pulse and unstable: synchronized cardioversion. Pulseless VT or VF: defibrillate immediately + high-quality CPR + epinephrine. Asystole / PEA: CPR + epinephrine — do NOT shock. (Shocking asystole is a classic distractor.)

Bradycardia (symptomatic): atropine → transcutaneous pacing → dopamine or epinephrine infusion.

Blocks: 1st degree (PR >0.20, benign) · 2nd degree Type I/Wenckebach (progressive PR lengthening then a dropped beat) · 2nd degree Type II (dropped beats without warning — can progress abruptly) · 3rd degree/complete (P waves and QRS independent → pacemaker).

Pacemaker/ICD teaching: check pulse daily; no arm elevation above shoulder for 4–6 weeks; avoid strong magnetic fields, arc welding, MRI unless the device is MRI-conditional; hold a cell phone to the opposite ear; carry the device card; report hiccups or twitching (lead displacement), fever/redness at the site, dizziness or syncope; report ICD shocks.

7.5 + NEW Anticoagulants, antiplatelets, thrombolytics

Drug Monitor Antidote / reversal Nursing
Heparin (UFH) aPTT 1.5–2.5× control; anti-Xa Protamine sulfate Monitor platelets (HIT); bleeding precautions
Enoxaparin (LMWH) None routine (anti-Xa if renal/obese/pregnant) Protamine (partial) Subcutaneous, abdomen, do NOT expel the air bubble, do NOT aspirate or massage; rotate sites
Warfarin INR 2–3 (2.5–3.5 mechanical valve); PT Vitamin K (phytonadione); PCC/FFP for major bleed Consistent — not zero — vitamin K intake; enormous interaction list; teratogenic; effect takes 3–5 days (bridge with heparin)
DOACs — apixaban, rivaroxaban (factor Xa); dabigatran (direct thrombin) No routine monitoring Andexanet alfa (Xa inhibitors); idarucizumab (dabigatran) Renal dosing; do not open/crush dabigatran capsules; adherence is critical (short half-life)
Antiplatelets — aspirin, clopidogrel, ticagrelor, prasugrel Platelet function if needed None specific Hold before surgery per protocol; GI upset/bleeding
Thrombolytics — alteplase, tenecteplase Fibrinogen, bleeding Aminocaproic acid; cryoprecipitate Screen contraindications; minimize punctures; monitor neuro status

Universal bleeding precautions: soft toothbrush, electric razor, no rectal temperatures or suppositories, no IM injections, avoid NSAIDs/aspirin unless prescribed, hold pressure longer after venipuncture, fall prevention, monitor for occult bleeding (stool, urine, gums, headache/neuro change).

7.6 + NEW Venous thromboembolism

Virchow's triad: venous stasis + endothelial injury + hypercoagulability. ↩U3 — this is why post-op patients ambulate. DVT: unilateral calf/thigh swelling, warmth, erythema, pain, ↑circumference. Do not massage the extremity. Diagnose with duplex ultrasound; D-dimer rules out. 🚩 PE ↩U4: sudden dyspnea, pleuritic chest pain, tachycardia, anxiety, hypoxemia, hemoptysis. Priority: oxygen and semi-Fowler's first, then notify, then anticoagulate. This is a breathing emergency before it is a clotting problem. Prevention: early ambulation, sequential compression devices, prophylactic anticoagulation, hydration.

7.7 Anemias

Classify by MCV. Shared presentation: fatigue, pallor, dyspnea on exertion, tachycardia, dizziness.

Anemia Distinctive features Management
Iron deficiency Microcytic, hypochromic; pica, spoon nails (koilonychia), glossitis. Find the source — menorrhagia in premenopausal women, GI bleed/colon cancer in everyone else Oral iron on an empty stomach with vitamin C; expect dark stools; liquid form through a straw (stains teeth); constipation; IV iron if intolerant
B12 / pernicious Macrocytic + NEUROLOGIC symptoms (paresthesia, ataxia, ↓proprioception, cognitive change); absent intrinsic factor, gastric surgery, ileal disease ↩U5 Lifelong B12 injections (oral fails without intrinsic factor). Neuro damage may be permanent if treatment is delayed
Folate Macrocytic, NO neurologic symptoms Folate; prevents neural tube defects — relevant to your U10 epilepsy-and-pregnancy content
Aplastic Pancytopenia — all three cell lines Transfusion, immunosuppression, hematopoietic cell transplant; neutropenic + bleeding precautions
Thalassemia Genetic, chronic hemolysis, microcytic Transfusion + iron chelation. Never give iron — these patients are iron-overloaded
Anemia of CKD →U8 Normocytic; ↓erythropoietin ESAs targeting Hgb 10–11 g/dL — not higher (↑thrombosis/stroke above target) + iron

The B12-versus-folate discriminator is the neurologic exam. Both are macrocytic; only B12 damages nerves.

7.8 + NEW Sickle cell disease

Autosomal recessive hemoglobin S. Deoxygenated HbS polymerizes → rigid sickled cells → vaso-occlusion + hemolysis. Triggers: hypoxia, dehydration, infection, cold, physical/emotional stress, acidosis, high altitude.

🚩 Vaso-occlusive (pain) crisis: severe pain in bones, joints, chest, abdomen, back. Management: PAIN IS THE PRIORITY — scheduled/PCA opioids at adequate doses, aggressive hydration, oxygen, warmth (never cold — cold causes vasoconstriction and worsens sickling), rest. Equity note that is also a test-taking cue: Black patients with sickle cell are systematically under-treated for pain, wait longer in emergency departments, and are more often labeled drug-seeking. On HESI, when the stem describes a patient in a sickle cell crisis reporting 9/10 pain, believe the patient and medicate — the correct answer is essentially never "reassess in an hour" or "assess for drug-seeking behavior."

🚩 Acute chest syndrome — fever, chest pain, cough, hypoxia, new pulmonary infiltrate. The leading cause of death in sickle cell disease. Medical emergency: oxygen, antibiotics, analgesia, transfusion, incentive spirometry. Other crises: splenic sequestration (rapid splenomegaly + shock), aplastic (parvovirus B19), hyperhemolytic. Chronic management: hydroxyurea (increases fetal hemoglobin), folic acid, penicillin prophylaxis and vaccination in childhood, transcranial Doppler for stroke risk, chronic transfusion with chelation, newer agents (crizanlizumab, voxelotor) and gene therapies.

7.9 Blood transfusion

Protocol: large-bore IV (18–20 gauge); 0.9% normal saline ONLY (dextrose hemolyzes, LR's calcium clots); two-nurse verification of patient identifiers, blood type, unit number, and expiration; baseline vitals; stay with the patient for the first 15 minutes (severe reactions occur early); vitals at 15 minutes and per protocol; complete infusion within 4 hours.

🚩 Any suspected reaction — first action: STOP the transfusion. Keep the line open with normal saline using new tubing. Notify the provider and blood bank. Stay with the patient. Send the unit and tubing back.

Reaction Signs
Acute hemolytic (ABO incompatibility — worst) Fever, chills, flank/back pain, hypotension, hemoglobinuria, sense of doom, DIC
Febrile non-hemolytic (most common) Fever, chills, headache — leukocyte-reduced products reduce risk
Allergic / anaphylactic Urticaria and itching → bronchospasm, hypotension
TACO (circulatory overload) Dyspnea, crackles, JVD, hypertension — slow rate, diuretics, sit up
TRALI (acute lung injury) Acute respiratory distress, hypoxemia, hypotension, bilateral infiltrates within 6 h

TACO versus TRALI: overload runs the BP up; lung injury runs it down.

7.10 Thrombocytopenia and coagulopathy

Platelets 150,000–450,000. <50k bleeding with trauma · <20k spontaneous bleeding · <10k critical, spontaneous intracranial hemorrhage risk. ITP: autoimmune platelet destruction → corticosteroids → IVIG → thrombopoietin receptor agonists → splenectomy. 🚩 HIT (heparin-induced thrombocytopenia): platelet drop >50% typically 5–10 days after heparin exposure — paradoxically causes thrombosis, not bleeding. Action: stop ALL heparin, including flushes and heparin-coated catheters. Start a non-heparin anticoagulant (argatroban). Never give platelets.

+ NEW DIC: widespread microvascular clotting consumes platelets and clotting factors → simultaneous clotting and bleeding. Triggers: sepsis, obstetric emergencies, trauma, burns, malignancy. Labs: ↓platelets, ↓fibrinogen, ↑PT/aPTT, ↑↑D-dimer, schistocytes. Treat the underlying cause; support with FFP, cryoprecipitate, platelets.

+ NEW Neutropenia: ANC <500 = severe. Fever in a neutropenic patient is an emergency — cultures then antibiotics within one hour; do not wait for the source. Protective precautions: meticulous hand hygiene, no fresh flowers/standing water, well-cooked food, no rectal temperatures/suppositories/enemas, avoid crowds and sick contacts, no live vaccines, monitor for subtle signs (fever may be the only sign — the usual inflammatory findings require neutrophils to produce them).

7.11 Peripheral arterial disease — and the arterial/venous trap

PAD: atherosclerotic reduction of arterial flow. Risk: smoking (the strongest modifiable factor), diabetes, HTN, hyperlipidemia, age. Findings: intermittent claudication (reproducible pain with exercise, relieved by rest), rest pain relieved by dangling the leg, diminished/absent pulses, cool, pale, shiny, hairless skin, thick nails, delayed capillary refill. ABI <0.90.

Arterial (PAD) Venous insufficiency
Pulses Diminished or absent Present
Skin Cool, pale, shiny, hairless Warm, brown hemosiderin staining, edema
Ulcers Toes, lateral malleolus, pressure points — painful, punched-out, dry Medial malleolus — weepy, shallow, irregular, less painful
Position DANGLE (dependent) ELEVATE
Compression Contraindicated if severe Therapeutic

Hook: Arterial = dangle. Venous = elevate. Getting these backwards is one of the most common errors on this content. Management: smoking cessation, supervised exercise/walking program (walk to pain, rest, repeat), meticulous foot care, antiplatelet (aspirin/clopidogrel), cilostazol, statin, revascularization. 🚩 Acute arterial occlusion — the 6 P's: Pain, Pallor, Pulselessness, Paresthesia, Paralysis, Poikilothermia. Limb-threatening emergency; notify immediately, keep the limb dependent and at room temperature, do not elevate or apply heat/cold.

7.12 + NEW Aneurysm, valvular disease, endocarditis, pericarditis

  • Abdominal aortic aneurysm: often asymptomatic; pulsatile periumbilical mass with a bruit — do not palpate deeply. Elective repair when >5.5 cm or rapidly enlarging. 🚩 Rupture: sudden severe back/flank/abdominal pain + hypotension + pulsatile mass = surgical emergency. Post-repair: monitor peripheral pulses, urine output (renal ischemia), and lower-extremity motor/sensory function (spinal cord ischemia).
  • Aortic dissection: sudden tearing/ripping pain radiating to the back, blood pressure differential between arms. Control HR and BP aggressively — beta-blocker first, then vasodilator (vasodilator alone increases shear stress).
  • Aortic stenosis: the triad syncope, angina, dyspnea; harsh systolic ejection murmur; avoid excessive preload reduction.
  • Infective endocarditis: fever + new or changed murmur; Osler nodes (painful, fingertips), Janeway lesions (painless, palms/soles), splinter hemorrhages, Roth spots; risk with injection drug use, prosthetic valves, prior endocarditis. Three sets of blood cultures from separate sites before antibiotics; weeks of IV antibiotics; antibiotic prophylaxis before dental procedures in high-risk patients only.
  • Pericarditis: sharp, pleuritic chest pain that worsens lying flat and is relieved by sitting up and leaning forward; friction rub; diffuse ST elevation. NSAIDs + colchicine. 🚩 Cardiac tamponade: Beck's triad — JVD, muffled heart sounds, hypotension — plus pulsus paradoxus and narrowed pulse pressure → pericardiocentesis.

7.13 + NEW Shock — the cross-cutting emergency

Type Mechanism Distinguishing finding
Hypovolemic Volume loss (hemorrhage, GI losses, burns) Flat neck veins, ↓CVP, cool clammy skin
Cardiogenic Pump failure (MI) JVD and pulmonary edema together
Septic (distributive) Vasodilation + capillary leak Early: warm, flushed, bounding, ↑lactate. Late: cold and mottled
Anaphylactic (distributive) Massive histamine release Urticaria, angioedema, stridor/wheeze → epinephrine IM immediately
Neurogenic (distributive) Loss of sympathetic tone (spinal injury above T6) The only shock with BRADYCARDIA + hypotension + warm, dry skin
Obstructive Mechanical (PE, tamponade, tension pneumothorax) JVD with clear or unilateral lung findings

Compensatory stage is where you catch it: tachycardia, tachypnea, narrowing pulse pressure, restlessness/anxiety (the earliest sign of cerebral hypoperfusion), cool clammy skin, decreasing urine output (<0.5 mL/kg/h). Blood pressure falls late. Sepsis bundle: measure lactate, obtain blood cultures before antibiotics, broad-spectrum antibiotics within 1 hour, 30 mL/kg crystalloid for hypotension or lactate ≥4, vasopressors (norepinephrine first-line) for persistent hypotension.

7.14 Unit 7 red flags

  • Chest pain + ST elevation → PCI clock starts; aspirin chewed now
  • Diabetic or older woman with fatigue, dyspnea, or "indigestion" → think MI anyway
  • Nitroglycerin ordered + PDE-5 inhibitor in the last 24–48 h → do not give
  • Pink frothy sputum → acute pulmonary edema; sit up, oxygen, loop diuretic
  • Apical HR 52 with digoxin due → hold and notify
  • K⁺ 3.1 in a patient on digoxin and furosemide → toxicity risk; report
  • Platelet drop 5–10 days into heparin → HIT; stop all heparin
  • Any transfusion reaction → stop, NS with new tubing, notify
  • Sickle cell + fever + chest pain + hypoxia → acute chest syndrome
  • Sudden dyspnea + pleuritic pain post-op → PE; oxygen first
  • Cool, pulseless, painful extremity → acute arterial occlusion
  • Tearing back pain + arm-to-arm BP difference → aortic dissection
U8 Genitourinary & RenalFrame: make · store · expel 5+ · 14🚩

Through-line: make · store · expel. The kidney makes urine (AKI, CKD, glomerular disease), the bladder stores it (incontinence, retention), and the outflow tract expels it (BPH, stones, strictures). Every U8 topic breaks at one of those three points. Anchors: your 68-year-old BPH→TURP patient, the recurrent-UTI woman, the renal-colic patient.

8.1 The five GU failure modes

Problem Break point Key
BPH Expel (obstruction) TURP → continuous bladder irrigation; TURP syndrome = dilutional hyponatremia
Erectile dysfunction Function PDE-5 inhibitor + nitrate = fatal hypotension ↩7.3
Incontinence Store (leak) Five types; behavioral first, then pharmacology
UTI Infection Upper tract = CVA tenderness + fever; → urosepsis
Calculi Expel (obstruction) Renal colic = writhing patient; strain all urine

8.2 Benign prostatic hyperplasia and TURP

Non-malignant prostatic enlargement compressing the urethra. LUTS: hesitancy, weak stream, straining, intermittency, incomplete emptying, frequency, urgency, nocturia. Complications: retention, UTI, hydronephrosis, renal insufficiency.

Class Drugs Pearl
Alpha-1 blockers (-osin) Tamsulosin, doxazosin, terazosin Rapid symptom relief (days). First-dose orthostatic syncope — give at bedtime. Also lowers BP ↩7.1. Retrograde ejaculation. Floppy iris syndrome — tell the ophthalmologist before cataract surgery →U10
5-alpha-reductase inhibitors Finasteride, dutasteride Shrinks the gland — 3–6 months for effect. Lowers PSA by ~50% — double the value when screening. Teratogenic: pregnant or potentially pregnant people must not handle crushed/broken tablets
Combination / PDE-5 Tadalafil Treats BPH and ED; nitrate contraindication stands

TURP nursing — a reliable HESI target: - Continuous bladder irrigation (CBI) with isotonic solution. Output = total drainage minus irrigant instilled — chart true urine output separately. - Priority: keep the catheter draining. Obstruction is the emergency. Clots, bladder spasm, decreased output, suprapubic distension, and increasing pain mean occlusion → increase the irrigation rate; hand-irrigate per order. - Expected: light pink to pink-tinged return that clears over the first 24 hours. - 🚩 Bright red drainage with clots = arterial bleeding → increase irrigation and notify the surgeon. - Traction on the catheter (taped to the thigh) provides tamponade — do not release it without an order. - Bladder spasms are common — antispasmodics (belladonna and opium suppositories, oxybutynin); do not simply increase irrigation for spasm alone. - 🚩 TURP SYNDROME: absorption of hypotonic irrigation fluid → dilutional hyponatremia. Confusion, restlessness, headache, nausea, bradycardia, hypertension, visual changes, seizures. ↩ This is Exam 1's "Na⁺ <120 = cerebral edema" rule in a surgical wrapper. Stop the irrigation, notify immediately, anticipate hypertonic saline. - Teaching: avoid straining/heavy lifting/constipation for 4–6 weeks; expect intermittent hematuria for weeks; increase fluids; retrograde ejaculation is common and not harmful.

8.3 Erectile dysfunction

Vascular, neurologic, endocrine, medication-related (beta-blockers, thiazides, SSRIs, antipsychotics), or psychogenic. Frequently the first sign of cardiovascular disease — it warrants a cardiac workup, not just a prescription. PDE-5 inhibitors (sildenafil, tadalafil, vardenafil): 🚩 absolutely contraindicated with any nitrate — the combination causes profound, refractory hypotension. Caution with alpha-blockers (additive hypotension), severe cardiac disease. Report priapism >4 hours (emergency) and sudden vision or hearing loss.

8.4 Urinary incontinence

Type Mechanism Management
Stress ↑abdominal pressure (cough, laugh, lift) overcomes a weak sphincter Pelvic floor muscle training (Kegels) is first-line, weight loss, pessary, sling
Urge (overactive bladder) Detrusor overactivity Bladder training/timed voiding, antimuscarinics (oxybutynin, tolterodine — anticholinergic burden, confusion in older adults) or mirabegron (beta-3 agonist — safer cognitively, monitor BP)
Overflow Retention from obstruction or an underactive detrusor Relieve obstruction; bladder scan; intermittent catheterization; treat BPH
Functional Physical/cognitive barriers, not urinary tract disease Environment, scheduled toileting, accessible clothing, bedside commode
Mixed Stress + urge Combined approach

Non-pharmacologic first, always. In older adults, prefer mirabegron over anticholinergics — antimuscarinics add to anticholinergic burden and can precipitate delirium →U9.

8.5 Urinary tract infection

Lower (cystitis): dysuria, frequency, urgency, suprapubic pain, cloudy/malodorous urine, hematuria. Upper (pyelonephritis): the lower symptoms plus fever, chills, flank pain, and CVA tenderness, nausea/vomiting. → risk of urosepsis. 🚩 In an older adult, new confusion may be the only presentation. New-onset delirium in an elder = look for UTI, hypoxia, dehydration, medications ↩U4 · →U9. But: asymptomatic bacteriuria is common in older adults and is not treated — a positive culture without symptoms is not an infection.

Antibiotics: nitrofurantoin, TMP-SMX, fosfomycin for uncomplicated cystitis. 🚩 Nitrofurantoin and fosfomycin do NOT achieve adequate renal parenchymal concentrations — never for pyelonephritis (fluoroquinolone, ceftriaxone, or aminoglycoside instead). ↩U4 Sulfonamides: Stevens-Johnson, photosensitivity, hyperkalemia, crystalluria — push fluids. Fluoroquinolones: tendon rupture, QT prolongation, CNS effects. Prevention teaching: adequate fluids, void every 2–3 hours and after intercourse, front-to-back wiping, cotton underwear, avoid spermicides/diaphragms if recurrent, cranberry has weak evidence. CAUTI prevention: insert only when indicated, sterile technique, keep the bag below bladder level and off the floor, maintain a closed system, secure the tubing, remove as early as possible — duration is the dominant risk factor.

8.6 Urolithiasis (renal calculi)

Types: calcium oxalate (most common), calcium phosphate, uric acid, struvite (infection-associated, staghorn), cystine. 🚩 Renal colic: excruciating flank pain radiating to the groin/labia/testicle, the patient cannot find a comfortable position and writhes — the diagnostic contrast with peritonitis, where the patient lies perfectly still ↩6.5. Hematuria, nausea/vomiting, diaphoresis. Diagnosis: non-contrast CT. Management: pain control first (NSAIDs ± opioids), hydration, strain all urine and send the stone for analysis, alpha-blocker (tamsulosin) as medical expulsive therapy for distal stones, lithotripsy or ureteroscopy for larger stones. 🚩 Obstructing stone + fever = urologic emergency — infection behind an obstruction becomes urosepsis rapidly; requires urgent decompression (stent or nephrostomy), not just antibiotics. Prevention by type: ≥2.5–3 L fluid daily for everyone; calcium oxalate → limit oxalate (spinach, rhubarb, nuts, tea, chocolate) but do not restrict dietary calcium; uric acid → limit purines, alkalinize urine, allopurinol; struvite → treat infection.

8.7 + NEW Acute kidney injury

Abrupt decline in kidney function with retention of nitrogenous waste. KDIGO criteria: creatinine rise ≥0.3 mg/dL within 48 h, or ≥1.5× baseline within 7 days, or urine output <0.5 mL/kg/h for ≥6 h.

Category Mechanism Causes Urine/lab signature
Prerenal (~60%) ↓perfusion; kidney is structurally intact Hypovolemia, hemorrhage, HF, sepsis, cirrhosis, NSAIDs, ACEi/ARB, renal artery stenosis BUN:Cr >20:1, urine Na⁺ <20, FENa <1%, concentrated urine, high specific gravity
Intrarenal / intrinsic Structural damage — usually acute tubular necrosis Prolonged ischemia; nephrotoxins: aminoglycosides, vancomycin, amphotericin, NSAIDs, contrast; rhabdomyolysis (myoglobin), hemolysis; glomerulonephritis; acute interstitial nephritis BUN:Cr ~10–15:1, urine Na⁺ >40, FENa >2%, muddy brown granular casts, isosthenuric urine (SG ~1.010)
Postrenal Obstruction BPH, stones, tumor, blocked catheter, neurogenic bladder Bladder scan; obstruction relief reverses it

Prerenal is reversible if you restore perfusion; sustained prerenal injury becomes ATN. That progression is the reason fluid status is the priority assessment.

The four phases — HESI tests which complication belongs to which:

Phase Duration Danger
Onset/initiation Hours–days The insult; often subtle
Oliguric 8–14 days (up to weeks) <400 mL/day. HYPERKALEMIA (the killer), metabolic acidosis, fluid overload/pulmonary edema, hypertension, ↑BUN/Cr, hyperphosphatemia, hypocalcemia, hyponatremia
Diuretic 1–3 weeks Up to 3–5 L/day. Now the risk flips: HYPOkalemia, hyponatremia, hypovolemia, dehydration. Nitrogenous wastes begin to fall late in this phase
Recovery Up to 12 months Gradual return of function; some do not fully recover

🚩 Hyperkalemia is the leading cause of death in AKI. ECG: peaked T waves → widened QRS → loss of P waves → sine wave → arrest. Treatment sequence — memorize the order: 1. IV calcium gluconate — stabilizes the myocardium. Does not lower potassium. Buys time. 2. Shift it in: regular insulin with dextrose (±albuterol nebulized; sodium bicarbonate if acidotic). 3. Remove it: loop diuretic if urine output preserved; potassium binder (sodium zirconium cyclosilicate, patiromer, sodium polystyrene sulfonate); dialysis is definitive.

Nursing priorities in AKI: strict I&O and daily weights (the most sensitive fluid indicator), fluid restriction in the oliguric phase, potassium restriction and holding potassium-sparing agents/ACEi/ARB/NSAIDs, adjust all renally cleared drug doses, monitor for infection (the leading cause of death overall in AKI), nutrition support. Contrast-associated AKI prevention: isotonic IV hydration before and after, use the minimum contrast volume, hold metformin at the time of the study and for 48 hours after (lactic acidosis risk), avoid stacking nephrotoxins.

8.8 + NEW Chronic kidney disease

Progressive, irreversible loss of nephrons ≥3 months. Causes: diabetes (#1) and hypertension (#2).

Staging by eGFR: G1 ≥90 · G2 60–89 · G3a 45–59 · G3b 30–44 · G4 15–29 · G5 <15 (ESRD, requires replacement therapy). Staged jointly with albuminuria: A1 <30, A2 30–300, A3 >300 mg/g — albuminuria predicts progression independently of GFR.

Uremic manifestations, by system: - Neuro: fatigue, difficulty concentrating, asterixis, peripheral neuropathy, restless legs, encephalopathy, seizures - Cardiac: hypertension, HF, uremic pericarditis (friction rub — a dialysis indication), accelerated atherosclerosis (the #1 cause of death in CKD) - Heme: anemia (↓erythropoietin), platelet dysfunction → bleeding despite a normal count - GI: anorexia, nausea, metallic taste, uremic fetor, GI bleeding - Skin: pruritus (phosphate deposition), sallow/gray color, uremic frost (late) - Metabolic: metabolic acidosis ↩ (the kidney can neither excrete acid nor regenerate bicarbonate — this is why CKD lives in the same acid-base framework you already know), hyperkalemia, hyperphosphatemia, hypocalcemia

🚩 CKD–mineral and bone disorder: the failing kidney can't activate vitamin D or excrete phosphate → ↑phosphate, ↓calcium → secondary hyperparathyroidism → the parathyroid pulls calcium out of bone → renal osteodystrophy (fractures) plus vascular calcification. Management: phosphate binders given WITH meals (calcium acetate, sevelamer, lanthanum — the timing is the point: they bind phosphate in food, not in blood), active vitamin D (calcitriol), calcimimetics, dietary phosphate restriction (dairy, cola, processed foods, nuts).

Pharmacologic management (KDIGO 2024): SGLT2 inhibitors are now recommended broadly in CKD — for type 2 diabetes with CKD at eGFR ≥20, and for CKD with eGFR ≥20 plus urine ACR ≥200 mg/g or with heart failure regardless of albuminuria; RAS inhibitors (ACEi or ARB) for CKD with moderate-to-severe albuminuria, continued even when eGFR falls below 30, and never combined ACEi + ARB + direct renin inhibitor; and a nonsteroidal MRA (finerenone) for type 2 diabetes with CKD, eGFR >25, normal potassium, and persistent albuminuria on maximally tolerated RAS inhibition — monitor potassium closely. Statins for cardiovascular risk. Nephrotoxin stewardship and sick-day medication rules (hold RAS inhibitors, SGLT2 inhibitors, diuretics, NSAIDs, and metformin during acute dehydrating illness) are emphasized as core patient education.

Diet: sodium restriction; potassium restriction (avoid bananas, oranges, potatoes, tomatoes, avocado, salt substitutes — salt substitutes are potassium chloride and are a classic HESI trap); phosphate restriction; moderate protein restriction pre-dialysis but increased protein once on hemodialysis (dialysis removes amino acids); fluid allowance ≈ 500–600 mL plus the previous day's urine output. Anemia: ESAs to a target hemoglobin of 10–11 g/dL — not normal (higher targets increase stroke and thrombotic events) plus iron repletion.

8.9 + NEW Dialysis and vascular access

Hemodialysis — typically 3–4 hours, three times weekly.

Access Maturation Notes
AV fistula (artery-to-vein anastomosis) 6 weeks–4 months Preferred — lowest infection and thrombosis risk, longest survival
AV graft (synthetic) 2–4 weeks Faster, higher infection/clotting risk
Central venous catheter Immediate Highest infection risk; bridge only

🚩 Access nursing — near-guaranteed test content: - Assess patency every shift: PALPATE for a thrill, AUSCULTATE for a bruit. Absent thrill/bruit = clotted = notify immediately. - NO blood pressures, venipunctures, IV starts, injections, or constrictive clothing/jewelry in the access extremity. Post a sign. - Assess distal circulation — cool, pale, numb, or painful hand suggests steal syndrome. - Hold pressure without occluding after needle removal; monitor for bleeding.

Around a dialysis run: weigh before and after (the difference is fluid removed); hold antihypertensives and dialyzable medications until after treatment (check the list — many antibiotics, digoxin, and water-soluble vitamins are removed); assess for hypotension, cramping, nausea. 🚩 Dialysis disequilibrium syndrome: rapid urea clearance from blood creates an osmotic gradient pulling water into the brain → headache, nausea, restlessness, confusion, seizures, usually during or just after early treatments. Slow or stop the rate and notify.

Peritoneal dialysis — dialysate instilled via a peritoneal catheter, dwells, then drains by gravity. - 🚩 Peritonitis is the #1 complication. CLOUDY EFFLUENT is the cardinal sign — report immediately (also abdominal pain, fever, rebound). Meticulous aseptic technique at every exchange. - Outflow less than inflow: reposition the patient, check for kinks, ensure the bag is below the abdomen, treat constipation (a full colon is the most common cause). - Warm the dialysate (never in a microwave) — cold fluid causes cramping. - Expect protein loss in the effluent → higher protein diet; monitor glucose (dextrose absorption). - Advantages: home-based, continuous, more dietary latitude, no anticoagulation.

+ NEW Kidney transplant: immunosuppression is lifelong (calcineurin inhibitors, mycophenolate, steroids) → infection and malignancy risk; teach sun protection, avoid live vaccines and crowds, meticulous hygiene. 🚩 Rejection signs: fever, tenderness over the graft, decreased urine output, rising creatinine, weight gain, hypertension, malaise. Report immediately. Never miss immunosuppressant doses.

8.10 + NEW Glomerular disease, PKD, and cancers

  • Acute glomerulonephritis (classically post-streptococcal): hematuria — tea/cola-colored urine, proteinuria, edema (periorbital, especially on waking), hypertension, oliguria, ↑BUN/Cr, ↑ASO titer. Supportive: sodium/fluid/protein restriction, BP control, treat the infection.
  • Nephrotic syndrome: massive proteinuria (>3.5 g/day), hypoalbuminemia, generalized edema/anasarca, hyperlipidemia, hypercoagulability (loses antithrombin III → thrombosis risk). ACEi/ARB, diuretics, statin, sometimes steroids; monitor for infection (loses immunoglobulins).
  • Discriminator: nephritic = blood and hypertension; nephrotic = protein and profound edema.
  • Polycystic kidney disease: autosomal dominant; flank pain, hematuria, hypertension, palpable kidneys, progression to ESRD; associated cerebral aneurysms — a severe sudden headache warrants urgent evaluation →U9. Genetic counseling; tolvaptan slows progression.
  • Prostate cancer: most common non-skin cancer in men. Often asymptomatic early; PSA drawn BEFORE a digital rectal exam; shared decision-making about screening. Post-prostatectomy: incontinence and erectile dysfunction are the dominant quality-of-life issues — Kegels, realistic teaching.
  • Bladder cancer: painless gross hematuria is the classic presenting sign — always warrants workup. Smoking is the dominant risk factor. Cystectomy with urinary diversion (ileal conduit — stoma with continuous urine output and mucus in the urine is normal; continent reservoir; neobladder).
  • Testicular cancer: ages 15–35; painless firm mass; monthly self-exam after a warm shower; markers AFP, β-hCG, LDH; highly curable.
  • 🚩 Testicular torsion: sudden severe unilateral scrotal pain, high-riding testis, absent cremasteric reflex, nausea. Surgical emergency — the salvage window is roughly 6 hours.

8.11 Unit 8 red flags

  • Post-TURP bright red drainage with clots → increase irrigation, notify
  • Post-TURP confusion, bradycardia, hypertension, ↓Na⁺ → TURP syndrome
  • Nitrate ordered for a patient on a PDE-5 inhibitor → withhold
  • New confusion in an older adult → UTI/hypoxia/dehydration/medication until proven otherwise
  • Obstructing stone + fever → urosepsis emergency, needs decompression
  • K⁺ 6.2 with peaked T waves in AKI → calcium gluconate first
  • Absent thrill or bruit over an AV fistula → clotted access, notify
  • Cloudy peritoneal dialysis effluent → peritonitis, notify
  • Headache, nausea, confusion during dialysis → disequilibrium syndrome
  • Painless gross hematuria → bladder cancer workup
  • Sudden severe scrotal pain → torsion, six-hour clock
  • Salt substitute in a CKD teaching scenario → it is potassium chloride; contraindicated
U9 Neurological — Degenerative & PainFrame: neurons die · transmitter missing · pain misfires 6+ · 15🚩

Through-line: neurons die · a transmitter goes missing · pain misfires. Alzheimer's is loss of neurons; Parkinson's is loss of dopamine; myasthenia is loss of receptor signal; migraine and neuropathy are misfiring signal. Anchors: your 76-year-old with Alzheimer's and acute-on-chronic confusion, the 68-year-old with Parkinson's, the migraine patient.

9.1 + NEW Baseline neuro assessment

Level of consciousness is the earliest and most sensitive indicator of neurologic change — before pupils, before vital signs. Any change in LOC gets reported. Glasgow Coma Scale (3–15): eye opening (4), verbal (5), motor (6). ≤8 = consider intubation. A drop of 2 points is significant. Pupils: size, equality, reactivity. A new unilateral fixed dilated pupil suggests uncal herniation — emergency. Pinpoint pupils suggest opioids or pontine lesion. 🚩 Cushing's triad (late sign of increased ICP): rising systolic pressure with WIDENING pulse pressure, BRADYCARDIA, and irregular respirations. By the time you see it, herniation is near. ↩U2 Never give hypotonic fluids to a patient with increased ICP or head injury — they worsen cerebral edema. Hypertonic saline (3%) and mannitol are the osmotic therapies; keep the head midline, HOB 30°, avoid hip flexion and Valsalva, cluster care to limit stimulation.

9.2 Delirium versus dementia — the keystone discriminator

Delirium Dementia
Onset Acute (hours–days) Gradual (months–years)
Course Fluctuating, often worse at night Steadily progressive
Attention Markedly impaired Preserved until late
Consciousness Altered Clear until late
Reversibility YES — find and fix the cause No

🚩 New confusion in a hospitalized older adult is delirium until proven otherwise. Hunt the reversible cause: infection (especially UTI ↩U8), hypoxia, electrolytes (Na⁺, Ca²⁺, glucose), medications (anticholinergics, benzodiazepines, opioids), pain, dehydration, constipation/retention, sleep deprivation, alcohol withdrawal. Management: treat the cause, reorient, family presence, familiar objects, glasses and hearing aids on, mobilize, normalize the sleep-wake cycle, adequate light, avoid restraints. Antipsychotics only for danger, at the lowest dose, briefly. 🚩 Antipsychotics in older adults with dementia carry a boxed warning for increased mortality.

9.3 Alzheimer's disease and other dementias

Progressive: short-term memory loss → language and executive deficits → agnosia/apraxia → total dependence. Drugs: cholinesterase inhibitors (donepezil, rivastigmine, galantamine — bradycardia, GI upset, vivid dreams; modest symptomatic benefit) and memantine (NMDA antagonist, moderate-to-severe disease). Newer anti-amyloid monoclonal antibodies (lecanemab, donanemab) require MRI monitoring for amyloid-related imaging abnormalities. Nursing: consistent routine and caregiver, simple one-step directions, break tasks down, redirect rather than argue or reality-orient into distress, safety first — wandering (door alarms, ID bracelet), driving, stove, medications, falls, evening "sundowning" (increase light, reduce stimulation), swallowing and aspiration risk later ↩U4, skin/continence care, caregiver strain is a nursing diagnosis — respite, support groups, advance directives early. Other dementias worth distinguishing: vascular (stepwise decline, focal findings); Lewy body (visual hallucinations, parkinsonism, fluctuating cognition — severe sensitivity to antipsychotics); frontotemporal (personality/behavior change first, younger onset).

9.4 Parkinson's disease

Degeneration of dopaminergic neurons in the substantia nigra → dopamine deficit relative to acetylcholine. Cardinal signs — TRAP: Tremor (resting, pill-rolling, decreases with movement), Rigidity (cogwheel), Akinesia/bradykinesia, Postural instability. Plus masked facies, shuffling festinating gait, micrographia, hypophonia, drooling, freezing, constipation, orthostatic hypotension, depression, late dementia.

Drug Pearl
Carbidopa–levodopa Gold standard. Timing is sacred — give exactly on schedule; a late dose means an "off" period of immobility. Separate from high-protein meals (dietary amino acids compete for the same transporter). Orthostatic hypotension, nausea, dyskinesias and wearing-off with long-term use, darkened sweat/urine (harmless)
Dopamine agonists (pramipexole, ropinirole) 🚩 Impulse-control disorders — pathologic gambling, hypersexuality, compulsive shopping and eating. Counsel the patient AND the family, because the patient often does not report it. Also somnolence/sleep attacks, hallucinations
MAO-B inhibitors (selegiline, rasagiline) Adjunct; avoid tyramine-rich foods at higher doses; serotonin syndrome risk with SSRIs/meperidine
COMT inhibitors (entacapone) Extends levodopa; brown-orange urine
Anticholinergics (benztropine, trihexyphenidyl) Tremor-predominant, younger patients; avoid in older adults — confusion, retention, constipation
Amantadine Dyskinesia; livedo reticularis

Nursing: fall prevention, swallowing evaluation and aspiration precautions, thickened liquids if needed, high-fiber diet and fluids for constipation, physical/occupational/speech therapy, allow extra time, warm baths and massage for rigidity, monitor for depression. Never abruptly stop levodopa — risk of a neuroleptic-malignant-like syndrome.

9.5 + NEW Multiple sclerosis

Autoimmune demyelination of the CNS; most commonly relapsing–remitting. Women, ages 20–40, higher latitudes. Findings: optic neuritis (painful monocular vision loss), diplopia/internuclear ophthalmoplegia, overwhelming fatigue, weakness, spasticity, ataxia, paresthesias, Lhermitte's sign (electric sensation down the spine with neck flexion), bladder dysfunction, cognitive changes, intention tremor. 🚩 Uhthoff's phenomenon: heat transiently worsens symptoms — avoid hot baths, hot tubs, saunas, overheating; cooling strategies are a nursing intervention, not a comfort measure. Acute relapse: high-dose IV methylprednisolone. Disease-modifying therapies: interferon beta (flu-like symptoms — dose at bedtime, premedicate), glatiramer, natalizumab (progressive multifocal leukoencephalopathy risk — JC virus testing), fingolimod (first-dose bradycardia — six-hour cardiac monitoring), ocrelizumab, dimethyl fumarate (flushing), teriflunomide (teratogenic). Symptom management: baclofen/tizanidine (spasticity), amantadine/modafinil (fatigue), oxybutynin or intermittent catheterization (bladder), gabapentin (neuropathic pain). Teaching: energy conservation and planned rest, avoid infection and extreme heat, exercise within tolerance, safety/fall prevention, the disease course is unpredictable — this is a chronic-illness-adjustment nursing problem as much as a neurologic one.

9.6 + NEW Myasthenia gravis — and the crisis discriminator

Autoantibodies against postsynaptic acetylcholine receptors at the neuromuscular junction. Often thymic pathology. Hallmark: DESCENDING weakness that worsens with activity and improves with rest — worst at the end of the day. Ptosis and diplopia are typically first; then dysphagia, dysarthria, chewing fatigue, proximal limb weakness, and respiratory muscle weakness. Diagnosis: acetylcholine receptor antibodies, edrophonium (Tensilon) test, EMG, chest imaging for thymoma. Treatment: pyridostigmine (anticholinesterase), immunosuppression, thymectomy, plasmapheresis/IVIG for crisis.

🚩 The classic HESI item — myasthenic versus cholinergic crisis. Both present with severe weakness and respiratory failure:

Myasthenic crisis Cholinergic crisis
Cause UNDER-medication, infection, stress, surgery, missed doses, certain drugs OVER-medication with anticholinesterase
Extra findings Tachycardia, ↑BP, restlessness, absent cholinergic signs SLUDGE — Salivation, Lacrimation, Urination, Defecation, GI cramping, Emesis — plus miosis, fasciculations, bradycardia, sweating
Edrophonium test Improves Worsens
Treatment More anticholinesterase; supportive ventilation Hold anticholinesterase; atropine; supportive ventilation

Both are airway emergencies. ↩ Monitor vital capacity and negative inspiratory force — not pulse oximetry. SpO₂ stays normal until the patient is nearly apneic, because the problem is ventilatory muscle failure, not gas exchange. Falling vital capacity is the early warning. Pyridostigmine timing: give 30–60 minutes BEFORE meals so the patient has strength to chew and swallow. 🚩 Drugs to avoid in myasthenia: aminoglycosides, magnesium, beta-blockers, certain antiarrhythmics, neuromuscular blockers.

9.7 + NEW Guillain–Barré syndrome

Autoimmune demyelination of peripheral nerves, typically 1–3 weeks after a respiratory or GI infection (Campylobacter jejuni classically). Hallmark: ASCENDING, symmetric, flaccid paralysis with areflexia, beginning in the legs. Paresthesias precede weakness. Ascending is the discriminator against myasthenia's descending pattern. 🚩 Priority is respiratory: serial vital capacity and negative inspiratory force; VC <15–20 mL/kg or a rapidly falling trend → prepare for intubation. Do not wait for hypoxia. Autonomic instability: labile blood pressure, dysrhythmias, ileus, urinary retention — continuous monitoring. Treatment: plasmapheresis or IVIG. Corticosteroids are NOT effective. Nursing: DVT and pressure injury prevention, nutrition, pain (often significant neuropathic pain), communication method while ventilated, reassurance — the patient is fully alert inside a paralyzed body, intensive rehabilitation. Most recover substantially.

9.8 + NEW ALS, Huntington's, and cranial neuropathies

  • ALS: degeneration of upper and lower motor neurons. Progressive weakness, fasciculations, spasticity, dysarthria, dysphagia, respiratory failure. Cognition, sensation, and bowel/bladder function are preserved — the person is fully aware throughout. Riluzole, edaravone; non-invasive ventilation; PEG placement. Advance directives and communication technology early — this is the nursing priority.
  • Huntington's: autosomal dominant; chorea, cognitive decline, psychiatric symptoms; genetic counseling; high suicide risk; aspiration and caloric needs.
  • Trigeminal neuralgia: paroxysmal, lancinating unilateral facial pain triggered by touch, chewing, wind, or cold. Carbamazepine is first-line. Nursing: avoid triggering the zone, room-temperature foods and fluids, small soft meals, protect from drafts.
  • Bell's palsy: acute unilateral facial nerve (CN VII) paralysis — the forehead is involved, which distinguishes it from stroke, where forehead sparing occurs. Corticosteroids ± antivirals early. Protect the eye: artificial tears, ointment and a patch at night — the patient cannot close the lid.

9.9 Headache and migraine

🚩 Headache red flags requiring urgent evaluation: - Thunderclap — sudden, maximal at onset, "worst headache of my life" → subarachnoid hemorrhage - Fever + nuchal rigidity + photophobia → meningitis (Kernig/Brudzinski; droplet precautions until cause known) - New headache with focal deficit, papilledema, seizure, or altered LOC - New headache after age 50, or in an immunocompromised or pregnant patient - Headache worsened by exertion, position, or Valsalva

Migraine: unilateral, throbbing, moderate-to-severe, with photophobia/phonophobia, nausea, ± aura; worsened by activity. Acute treatment: NSAIDs/acetaminophen early; triptans (sumatriptan) — 🚩 contraindicated in coronary artery disease, uncontrolled hypertension, and cerebrovascular disease (vasoconstriction); do not combine with ergots; ergotamines — same vascular contraindications plus absolute contraindication in pregnancy; antiemetics; gepants (ubrogepant, rimegepant) as a safer option in cardiovascular disease; ditans (lasmiditan — no driving for 8 hours). 🚩 Medication-overuse headache: treating more than ~10–15 days per month perpetuates the cycle. Prevention: CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) and gepants are now positioned as first-line preventives rather than last-resort; also topiramate (paresthesias, weight loss, kidney stones, teratogenic), beta-blockers, TCAs, valproate (teratogenic), botulinum toxin for chronic migraine. Nursing: identify triggers with a headache diary (sleep, stress, hormones, alcohol, aged cheese, nitrates, skipped meals, weather), dark quiet room during an attack, cold compress, treat early rather than waiting.

9.10 + NEW Pain — the second half of this unit

"Pain is whatever the experiencing person says it is, existing whenever they say it does." Self-report is the gold standard; there is no objective test, and normal vital signs do not disprove pain (autonomic responses adapt in chronic and persistent pain).

Assessment tools: numeric rating scale; Wong–Baker FACES (children, language barriers); FLACC (nonverbal, infants); PAINAD (advanced dementia); CPOT/BPS (critically ill, intubated). OLDCARTS/PQRST for characterization.

🚩 The equity dimension — and it is testable. Black patients are systematically under-assessed and under-treated for pain across emergency, surgical, and oncology settings, a disparity that persists after controlling for insurance, income, and disease severity, and is driven in part by false beliefs about biological differences in pain sensitivity. On HESI, the correct action when a patient reports severe pain is to believe and treat, not to delay, reassess later, or evaluate for drug-seeking behavior. This is where clinical correctness and justice point the same direction.

Pharmacology:

Tier Agents Nursing
Non-opioid Acetaminophen (max 3–4 g/day; hepatotoxicity — check every combination product); NSAIDs (GI bleeding, renal injury — avoid in CKD ↩U8, cardiovascular risk, avoid with anticoagulants) Foundation of multimodal analgesia; opioid-sparing
Opioid Morphine (avoid in renal failure — active metabolites accumulate), hydromorphone, oxycodone, fentanyl (transdermal is for opioid-tolerant chronic pain only — never opioid-naive; heat increases absorption) 🚩 Meperidine should be avoided — normeperidine accumulates and causes seizures
Adjuvant Gabapentin, pregabalin, duloxetine, TCAs (neuropathic); corticosteroids; lidocaine patch; ketamine Neuropathic pain responds poorly to opioids alone

🚩 Opioid safety: sedation precedes respiratory depression — a sedation scale is the early warning, not respiratory rate. Constipation is the one adverse effect that never develops tolerance → prophylactic stimulant laxative from day one ↩U5. Also nausea, pruritus, urinary retention, hypotension. Naloxone reverses but has a shorter half-life than most opioids — monitor for re-sedation and be prepared to re-dose; it precipitates withdrawal and returns the pain. 🚩 PCA: only the patient presses the button. No PCA by proxy — no family, no staff. The built-in safety is that a sedated patient cannot self-administer. Teach the patient to dose before activity; monitor sedation and respiratory rate. Non-pharmacologic: repositioning, heat/cold, massage, distraction, relaxation, guided imagery, music, TENS, acupuncture — adjuncts, not substitutes.

9.11 Unit 9 red flags

  • New confusion in a hospitalized older adult → delirium; hunt the cause
  • Thunderclap headache → subarachnoid hemorrhage
  • Fever + nuchal rigidity → meningitis
  • Widening pulse pressure + bradycardia + irregular respirations → Cushing's triad, late ICP
  • New unilateral fixed dilated pupil → herniation
  • Descending weakness with ptosis → myasthenia; check vital capacity
  • Ascending flaccid paralysis → Guillain–Barré; check vital capacity
  • SLUDGE symptoms in a myasthenic → cholinergic crisis; hold the drug, give atropine
  • Late levodopa dose → "off" period; timing is the intervention
  • New gambling or hypersexuality on a dopamine agonist → report; it is the drug
  • Triptan ordered for a patient with CAD → withhold
  • Antipsychotic requested for a patient with dementia → boxed-warning mortality risk; non-pharmacologic first
  • Patient reports 9/10 pain with normal vital signs → believe and treat
U10 Sensory & Seizure DisordersFrame: the electrical storm · the failing sensors 4+ · 14🚩

Through-line: the electrical storm (seizures) and the failing sensors (eye, ear). Both are safety units — almost every correct answer is a safety action. Anchors: your pregnancy-planning woman with epilepsy; the seizure that will not stop.

10.1 Seizure classification

Type Features
Focal aware (simple partial) Consciousness preserved; motor, sensory, or autonomic symptoms
Focal impaired awareness (complex partial) Altered awareness, automatisms (lip-smacking, picking), postictal confusion
Focal to bilateral tonic–clonic Begins focally, generalizes
Generalized tonic–clonic Loss of consciousness, tonic rigidity → clonic jerking, incontinence, tongue biting, postictal confusion and drowsiness
Absence Brief staring/blanking, no postictal phase — often mistaken for inattention in school
Myoclonic Brief shock-like jerks
Atonic ("drop attack") Sudden loss of tone; high injury risk — helmet

Phases: prodrome → aura (itself a focal seizure and a warning to get to safety) → ictal → postictal. Precipitants: missed medication doses (the most common), sleep deprivation, alcohol/withdrawal, infection/fever, flashing lights, stress, hypoglycemia, electrolyte derangement (↩ hyponatremia, hypocalcemia, hypomagnesemia).

10.2 Seizure nursing — during and after

During: - Stay with the patient. Time the seizure. - Turn side-lying (protects the airway), protect the head, loosen restrictive clothing, clear the area of hazards. - DO NOT restrain. DO NOT put anything in the mouth. Both cause injury; the tongue cannot be swallowed. - Suction and oxygen available; do not force a suction catheter or airway during the tonic phase. - Observe and document: onset, aura, motor pattern and progression, eye deviation, duration, incontinence, cyanosis, postictal state.

After: maintain side-lying, assess airway and vitals, suction as needed, reorient calmly and repeatedly, allow rest, assess for injury, privacy and dignity — witnessed seizures are humiliating. Hospital seizure precautions: bed in the low position, side rails padded and up, suction and oxygen at the bedside, IV access for high-risk patients, no oral temperatures, supervised ambulation and showering.

10.3 🚩 Status epilepticus

Definition: a seizure lasting ≥5 minutes, or repeated seizures without return to baseline between them. Mortality rises with duration; neuronal injury begins around 30 minutes.

Sequence — the order is the answer: 1. ABC — airway positioning, suction, oxygen, IV access, check glucose, cardiac and pulse-ox monitoring. 2. First-line: a benzodiazepine — IV lorazepam, or IM midazolam if no IV access, or rectal diazepam. 3. Second-line: an IV antiseizure medication — levetiracetam, fosphenytoin, or valproate. Comparative trial evidence found these three roughly equivalent, so any of them appearing as the correct option is defensible. 4. Refractory: anesthetic infusion (midazolam, propofol, pentobarbital) with intubation and continuous EEG. 5. Throughout: identify and treat the precipitant — hypoglycemia, hyponatremia, hypocalcemia, infection, drug withdrawal, missed doses, eclampsia.

🚩 Never stop antiseizure medications abruptly — abrupt withdrawal is a leading precipitant of status epilepticus.

10.4 + NEW Antiseizure medications

Drug Level Signature toxicity / teaching
Phenytoin 10–20 mcg/mL 🚩 IV compatibility: NORMAL SALINE ONLY — never dextrose (precipitates). Max rate 50 mg/min (fosphenytoin 150 mg PE/min) with cardiac monitoring — faster causes hypotension and dysrhythmias. Gingival hyperplasia — meticulous oral care and dental follow-up. Hirsutism, nystagmus → ataxia → confusion as the level climbs, rash/Stevens–Johnson, purple glove syndrome, folate depletion, osteoporosis. Strong CYP inducer
Carbamazepine 4–12 mcg/mL 🚩 Hyponatremia/SIADH (↩ — another route to Na⁺ <120), agranulocytosis and aplastic anemia — monitor CBC, Stevens–Johnson associated with HLA-B*1502 (screen patients of Asian ancestry), diplopia, ataxia. CYP inducer. First-line for trigeminal neuralgia ↩9.8
Valproate 50–100 mcg/mL 🚩 Highest teratogenic risk of any antiseizure medication — neural tube defects and reduced childhood IQ. Hepatotoxicity, pancreatitis, hyperammonemia, thrombocytopenia, weight gain, tremor, hair loss
Levetiracetam Not routinely monitored Behavioral and psychiatric effects — irritability, agitation, depression, suicidality. Renal dose adjustment. Minimal interactions; commonly preferred in pregnancy
Lamotrigine Not routinely monitored 🚩 Stevens–Johnson syndrome and toxic epidermal necrolysis — titrate slowly, much slower when combined with valproate. Any rash must be reported immediately. Otherwise favorable in pregnancy
Phenobarbital 15–40 mcg/mL Sedation, cognitive slowing, dependence, respiratory depression. Strong CYP inducer
Topiramate Not routinely monitored Word-finding difficulty, paresthesias, kidney stones (push fluids), weight loss, acute angle-closure glaucoma →10.6, teratogenic
Oxcarbazepine — Hyponatremia (like carbamazepine), better tolerated

🚩 Enzyme-inducing antiseizure medications — phenytoin, carbamazepine, phenobarbital, and topiramate at higher doses — accelerate hormone metabolism and REDUCE oral contraceptive efficacy. This is the single most important reproductive-health teaching point in the unit: patients need higher-dose or non-hormonal contraception, and unplanned pregnancy on valproate carries the highest fetal risk.

10.5 + NEW Epilepsy across the lifespan and childbearing

  • Preconception: folic acid (commonly 4 mg daily for patients on antiseizure medication), transition off valproate before conception if possible, switch toward lamotrigine or levetiracetam, and plan the pregnancy rather than react to it.
  • During pregnancy: monotherapy at the lowest effective dose; do not stop medication — uncontrolled seizures risk both patient and fetus; drug levels shift (lamotrigine and levetiracetam clearance increases markedly), so levels are monitored and doses adjusted; vitamin K in the third trimester with enzyme-inducing drugs.
  • Lifestyle: consistent sleep, medication adherence with alarms/pillboxes, alcohol moderation, state-specific driving restrictions after a seizure, avoid swimming alone, shower rather than bathe, avoid heights and unguarded machinery, medical alert identification, seizure action plan shared with family and employer, disclosure decisions and workplace protections.
  • Non-pharmacologic options: ketogenic diet, vagus nerve stimulation, responsive neurostimulation, resective surgery for drug-resistant focal epilepsy.
  • Stigma is a nursing problem. Epilepsy carries disproportionate social and employment consequences; teaching bystanders what a seizure is and is not is part of care.

10.6 + NEW Visual disorders

🚩 ACUTE ANGLE-CLOSURE GLAUCOMA — the ophthalmologic emergency. Sudden severe eye pain, headache, nausea and vomiting, blurred vision with halos around lights, a fixed mid-dilated pupil, and a hard red eye. Vision loss occurs within hours. Immediate: notify, do not delay. Treatment is topical miotics (pilocarpine), acetazolamide, hyperosmotics, and definitive laser peripheral iridotomy. 🚩 Avoid anticholinergics, mydriatics, and pupil-dilating drugs in anyone at risk — this is why "blurred vision and eye pain" in a patient on an anticholinergic, a topiramate, or a scopolamine patch is an urgent finding, not a side effect to document.

Primary open-angle glaucoma (far more common): painless, insidious loss of PERIPHERAL vision progressing to tunnel vision; central acuity preserved until late; elevated intraocular pressure (normal 10–21 mmHg); cupping of the optic disc. Damage is irreversible; treatment prevents further loss. Lifelong drops — never stop, even though the patient feels nothing. Adherence teaching is the intervention.

Drop class Examples Teaching
Prostaglandin analogs Latanoprost First-line, once daily at night. Permanent iris darkening, eyelash growth, periorbital pigmentation
Beta-blockers Timolol 🚩 Systemic absorption causes bradycardia and bronchospasm — caution in asthma/COPD ↩U4 and heart block. Teach punctal occlusion (press the inner canthus for 1–2 minutes) to reduce systemic uptake
Alpha agonists Brimonidine Allergic conjunctivitis, dry mouth, fatigue
Carbonic anhydrase inhibitors Dorzolamide, oral acetazolamide Sulfa-related; oral form causes paresthesias, ↓K⁺, kidney stones

Instillation technique (teachable and testable): wash hands, tilt head back, pull down the lower lid to form a pocket, do not touch the tip to the eye, apply gentle punctal occlusion, wait 5 minutes between different drops, instill drops before ointments.

Cataracts: painless progressive blurring, glare and halos around lights, faded colors, difficulty driving at night, second sight. Risks: age, UV exposure, smoking, diabetes, corticosteroids, trauma. Surgery is outpatient phacoemulsification with lens implant, one eye at a time. 🚩 Post-op teaching: no bending at the waist, no lifting over ~10 lb, no straining/Valsalva, treat constipation, no coughing or sneezing suppression, do not rub the eye, wear the eye shield at night and sunglasses in daylight, sleep on the unoperated side. Report immediately: sudden eye pain (hemorrhage or acute pressure rise), a sudden increase in floaters or flashes of light (retinal detachment), decreasing vision, purulent drainage.

Age-related macular degeneration: CENTRAL vision loss with preserved peripheral vision — the mirror image of glaucoma. Metamorphopsia (straight lines appear wavy) and a central scotoma. Dry (atrophic, ~90%) — drusen, gradual; AREDS2 supplementation slows progression in intermediate disease; smoking cessation is the strongest modifiable factor. Wet (neovascular) — abrupt distortion; intravitreal anti-VEGF injections. Teaching: an Amsler grid daily; any new distortion or dark central spot is reported the same day. Low-vision rehabilitation, magnification, high-contrast lighting.

🚩 Retinal detachment — emergency. Painless. Sudden floaters ("spiderwebs," "soot"), flashes of light (photopsia), and a curtain or shadow moving across the visual field. Risks: high myopia, cataract surgery, trauma, diabetic retinopathy. Action: notify immediately, keep the patient still, position as directed to let the detached area settle, avoid sudden head movement and Valsalva. Repair by pneumatic retinopexy, scleral buckle, or vitrectomy. If an intraocular gas bubble is placed: strict face-down or prescribed positioning, and NO AIR TRAVEL or high-altitude travel until the bubble resorbs — the gas expands and can blind the patient.

Diabetic retinopathy: microvascular damage; leading cause of new blindness in working-age adults. Annual dilated eye examination. Glycemic and blood pressure control are the primary interventions; laser photocoagulation and anti-VEGF for advanced disease.

10.7 + NEW Auditory and vestibular disorders

Conductive (outer/middle ear — cerumen impaction, otitis media with effusion, otosclerosis, perforation) versus sensorineural (inner ear or CN VIII — presbycusis, noise exposure, ototoxicity, Meniere's, acoustic neuroma) versus mixed. Weber test: lateralizes to the affected ear in conductive loss, away in sensorineural. Rinne: normally air conduction > bone conduction; reversed in conductive loss.

🚩 Ototoxic drugs — and note how many are already on your exam: aminoglycosides (gentamicin, tobramycin ↩U4), loop diuretics (furosemide ↩U7), vancomycin, cisplatin, high-dose salicylates, some antimalarials. Tinnitus is often the first sign — report it before hearing loss develops. Risk multiplies when agents are combined, and both aminoglycosides and loop diuretics are also nephrotoxic — a patient in AKI on both is at compounded risk ↩U8.

🚩 Meniere's disease — endolymphatic hydrops. The triad plus one: episodic, severe vertigo (minutes to hours) + tinnitus + fluctuating sensorineural hearing loss + aural fullness. Attacks come with nausea, vomiting, nystagmus, and profound imbalance. Nursing priority is SAFETY: during an attack, bed rest in a quiet, dimly lit room, side rails up, no sudden head movements, assist with all ambulation, no driving or operating machinery, no climbing or working at heights. Antiemetics and vestibular suppressants (meclizine, dimenhydrinate, benzodiazepines short-term), antihistamines/anticholinergics, sometimes intratympanic steroids. Between attacks: low-sodium diet, diuretics, limit caffeine, alcohol, and nicotine, manage stress, keep a symptom diary.

Other vestibular causes: BPPV — brief positional vertigo, diagnosed with the Dix–Hallpike maneuver and treated with the Epley repositioning maneuver; vestibular neuritis/labyrinthitis — acute, often post-viral, sustained vertigo. Otitis externa ("swimmer's ear"): pain on movement of the tragus or auricle; topical drops; keep the ear dry. Otitis media: ear pain, fever, bulging erythematous tympanic membrane, conductive loss. Acoustic neuroma: unilateral sensorineural loss with tinnitus and imbalance — unilateral hearing loss always warrants investigation.

Communicating with a person who has hearing loss: face the person at eye level in good light, get their attention first, speak in a normal-to-slightly-slower rate at a lower pitch — do not shout (shouting distorts speech and raises pitch, which is exactly the range lost in presbycusis), reduce background noise, rephrase rather than repeat, confirm understanding, ensure hearing aids are in and working. Never remove a hearing aid before surgery without a plan — sensory deprivation is a major contributor to perioperative delirium ↩9.2.

10.8 Unit 10 red flags

  • Seizure ≥5 minutes, or no recovery between seizures → status epilepticus; ABC then benzodiazepine
  • Anyone suggesting restraint or a mouth object during a seizure → wrong; side-lying and protect
  • Phenytoin ordered with D5W → normal saline only
  • Rash on lamotrigine → stop and report; Stevens–Johnson risk
  • Hyponatremia on carbamazepine → SIADH
  • Patient of childbearing potential started on valproate → highest teratogen; question it
  • Patient on an enzyme-inducing antiseizure drug using oral contraceptives → contraceptive failure risk
  • Sudden eye pain, halos, hard red eye, fixed mid-dilated pupil → acute angle-closure glaucoma
  • Sudden flashes, floaters, and a curtain across vision → retinal detachment
  • New wavy lines on the Amsler grid → wet AMD; same-day report
  • Post-cataract sudden pain or vision loss → emergency
  • Tinnitus in a patient on gentamicin or furosemide → early ototoxicity
  • Vertigo attack in Meniere's → safety first; the answer is almost always a fall-prevention action
The seams

Cross-system integration

This is what separates a 900 from an 1100 on a cumulative exam. HESI builds items at the joins between units — the same finding meaning different things, the drug that collides across two systems, the chain that starts in the liver and ends in the kidney. Drill this Saturday.

Electrolyte & acid–base bridges, chains, collisions, positioning, diet, delegation

This is the part that separates a 900 from a 1100 on a cumulative exam. HESI builds items at the seams between units. Drill this section Saturday.

4.1 Acid–base by source ↩U2

Source Disturbance Why
Diarrhea, ileostomy output, lower-GI loss Metabolic ACIDOSIS Loses bicarbonate-rich fluid from below
Vomiting, NG suction, upper-GI loss Metabolic ALKALOSIS Loses hydrochloric acid from above
AKI / CKD Metabolic ACIDOSIS Kidney can neither excrete acid nor regenerate bicarbonate
Loop and thiazide diuretics Metabolic alkalosis + hypokalemia Contraction alkalosis
Salicylate overdose Mixed respiratory alkalosis + metabolic acidosis Direct respiratory stimulation plus acid load
Respiratory muscle failure — myasthenic/cholinergic crisis, Guillain–Barré, opioid oversedation Respiratory ACIDOSIS Hypoventilation retains CO₂
Refeeding syndrome Not acid–base — ↓phosphorus, ↓potassium, ↓magnesium Insulin drives them intracellularly

One-line synthesis: lose acid from above → alkalosis; lose base from below or fail to excrete acid → acidosis.

4.2 Potassium across four units

Direction Where it comes from What kills
HYPOkalemia Diarrhea (U5) · NG suction/vomiting (U6) · loop and thiazide diuretics (U7) · AKI diuretic phase (U8) · insulin/DKA treatment · amphotericin, corticosteroids Dysrhythmias; potentiates digoxin toxicity (U7); flat T waves, U waves; ileus; muscle weakness
HYPERkalemia AKI oliguric phase and CKD (U8) · ACEi/ARB/ARNI, MRA, potassium-sparing diuretics (U7/U8) · salt substitutes · crush injury/rhabdomyolysis/hemolysis · acidosis (shifts K⁺ out of cells) · blood transfusion (older units) Peaked T waves → wide QRS → sine wave → arrest. Treatment order: calcium gluconate → insulin+dextrose → remove (binder/diuretic/dialysis)

If a single lab value could be the answer to "which finding requires immediate intervention," it is potassium.

4.3 Sodium across the exam

Cause Direction
TURP syndrome (U8) — hypotonic irrigant absorption ↓Na⁺, acute — seizure risk
Carbamazepine / oxcarbazepine (U10) — SIADH ↓Na⁺
Cirrhosis with ascites, heart failure (U6/U7) ↓Na⁺ (dilutional)
Diuretics, adrenal insufficiency ↓Na⁺
Dehydration, tube feeding without free water, diabetes insipidus ↑Na⁺

🚩 Acute Na⁺ <120 → cerebral edema → seizures. Correct slowly (rapid correction causes osmotic demyelination). Seizure precautions and neuro checks are the nursing answer.

4.4 Calcium, phosphorus, magnesium

  • Pancreatitis (U6) → hypocalcemia from fat saponification → Chvostek and Trousseau signs, tetany, laryngospasm, seizures.
  • CKD (U8) → hyperphosphatemia and hypocalcemia → secondary hyperparathyroidism → renal osteodystrophy. Phosphate binders WITH meals.
  • Refeeding (U6) → hypophosphatemia → respiratory and cardiac failure.
  • Loop diuretics and alcohol use → hypomagnesemia → refractory hypokalemia and torsades de pointes. You cannot correct the potassium until you correct the magnesium.
  • Calcium and phosphorus move inversely; calcium and magnesium move together clinically.

4.5 "One patient, three units" — the chains HESI actually builds items from

Each chain below is a plausible unfolding-case skeleton. Being able to see the whole chain from any one link is the skill being tested.

  1. HTN (U7) → CKD (U8) → anemia of CKD (U7) → fluid overload → heart failure (U7) → hyperkalemia (U8) → dysrhythmia (U7).
  2. Cirrhosis (U6) → portal hypertension → varices → hemorrhage → hypovolemic shock (U7) → prerenal AKI (U8) → hyperkalemia.
  3. Diabetes → CKD (U8) → dialysis → AV fistula → the arm that cannot be used for blood pressure (U8) → and diabetic retinopathy in the same patient (U10).
  4. Older adult with BPH (U8) → retention → UTI (U8) → delirium (U9) → fall → and the anticholinergic given for the bladder made the delirium worse (U8→U9).
  5. Crohn's (U5) → ileal disease → B12 deficiency → macrocytic anemia with neurologic findings (U7) → and the neuro findings could be mistaken for a primary neurologic disorder (U9).
  6. Myasthenia gravis (U9) → dysphagia → aspiration (↩U4) → and an aminoglycoside given for the resulting pneumonia worsens the myasthenia (U9) and threatens hearing (U10) and kidneys (U8).
  7. Seizure disorder (U10) → phenytoin → gingival hyperplasia and folate depletion → and the enzyme induction defeats her oral contraceptive (U10) while valproate would be the worst possible substitute in pregnancy.
  8. Post-op patient (↩U3) → immobility → DVT (U7) → PE (↩U4) → anticoagulation (U7) → GI bleed (U6).

4.6 Drug collisions — one patient, two units, one contraindication

Combination Consequence
PDE-5 inhibitor + nitrate Profound refractory hypotension (U8 + U7)
ACEi + ARNI Angioedema — 36-hour washout (U7)
ACEi/ARB + MRA + potassium supplement or salt substitute Hyperkalemia (U7 + U8)
Digoxin + loop or thiazide diuretic Hypokalemia → digoxin toxicity (U7)
Aminoglycoside + loop diuretic Compounded ototoxicity and nephrotoxicity (↩U4 + U7 + U8 + U10)
Enzyme-inducing antiseizure drug + oral contraceptive Contraceptive failure (U10)
Valproate + lamotrigine Markedly increased Stevens–Johnson risk; titrate much slower (U10)
Aminoglycoside, magnesium, or beta-blocker in myasthenia Precipitates crisis (U9)
Anticholinergic in narrow angles Acute angle-closure glaucoma (U10)
Anticholinergic in an older adult Delirium, retention, constipation (U8 + U9)
NSAID in CKD or on anticoagulation AKI; GI bleed (U8 + U6 + U7)
Triptan or ergot in coronary artery disease Vasospasm/ischemia (U9 + U7)
Metformin + iodinated contrast Lactic acidosis — hold 48 hours (U8)

4.7 Positioning master table

Situation Position
Arterial insufficiency / PAD Dangle, dependent
Venous insufficiency / DVT Elevate
Acute pulmonary edema, heart failure, dyspnea High Fowler's, legs dependent
Peritonitis, post-abdominal surgery Semi-Fowler's with knees flexed (localizes drainage, relieves tension)
Acute pancreatitis Side-lying knees flexed, or upright leaning forward
Tube feeding, GERD, aspiration risk HOB 30–45°
Seizure Side-lying
Increased ICP HOB 30°, head midline, avoid hip flexion
Post-cataract surgery Sleep on the unoperated side, eye shield
Retinal detachment with a gas bubble Prescribed positioning, often face-down
Meniere's attack Flat or side-lying in a quiet dark room, minimal head movement
Peritoneal dialysis with poor outflow Reposition the patient; drain bag below the abdomen
Autonomic dysreflexia / suspected shock with hypotension Sit up for dysreflexia; flat with legs elevated for hypovolemic shock

4.8 Diet master table

Condition Diet
CKD, pre-dialysis ↓sodium, ↓potassium, ↓phosphorus, moderate protein restriction
CKD on hemodialysis Same restrictions but increased protein
Fluid allowance in ESRD ≈ 500–600 mL + previous day's urine output
Heart failure ↓sodium (2–3 g); fluid restriction if hyponatremic
Cirrhosis with ascites ↓sodium; protein NOT restricted
Diverticulosis (prevention) High fiber
Diverticulitis (acute flare) Low fiber / bowel rest
Celiac Lifelong gluten-free
Post-bariatric Small frequent meals, no fluids with meals, avoid simple sugars
Calcium oxalate stones ↑fluids, ↓oxalate — do NOT restrict dietary calcium
Uric acid stones ↓purine, alkalinize urine
Chronic pancreatitis Low fat, enzymes with every meal, no alcohol
Parkinson's on levodopa Separate levodopa from high-protein meals
Meniere's Low sodium, limit caffeine/alcohol/nicotine
Warfarin Consistent — not absent — vitamin K intake
MAO-B inhibitor at higher doses Avoid tyramine
Iron supplementation Empty stomach with vitamin C; avoid with dairy, antacids, tea

4.9 Delegation across all six units ↩U1

Task RN LPN UAP
Initial stoma assessment after surgery ✔
Routine ostomy pouch emptying ✔ ✔
Blood transfusion verification and initiation ✔
Vital signs on a stable post-transfusion patient ✔ ✔
Assessing an AV fistula for thrill and bruit ✔
Reminding staff not to use the fistula arm for BP ✔ ✔ ✔ (reinforce)
Neuro checks / GCS ✔
Feeding a patient with dysphagia ✔ (assess first) ✖
Feeding a patient without swallowing risk ✔ ✔
Initial teaching on a new antiseizure medication ✔
Reinforcing previously taught seizure precautions ✔
Titrating a heparin drip ✔
Instilling routine glaucoma drops (stable patient) ✔ ✔ ✖
Assisting a Meniere's patient to ambulate ✔ ✔
Interpreting a rising creatinine ✔

The line: delegate the stable, routine, and predictable. Retain assessment, teaching, evaluation, and anything unstable or novel.


Active recall

Drill deck

Generate the answer out loud before you flip. Retrieval builds durable memory; re-reading builds false confidence. Filter to a unit, shuffle, and repeat the misses.

U5 1 / 1
—
tap to reveal
—
Self-assessment

30 applied items

Timed, no notes, no stopping — answer all thirty before you check anything. SATA items have no partial credit: judge each option independently instead of anchoring on how many you expect to be right.

—

—

answered 0/30
Sunday morning, twenty minutes

Cram sheet

If you read nothing else before you sit: these numbers and these red flags resolve a large fraction of HESI items on their own.

Labs — carried from Exam 1

  • Potassium 3.5–5.0 mEq/L
  • Sodium 135–145 mEq/L
  • Calcium 8.5–10.5 mg/dL
  • Magnesium 1.5–2.5 mEq/L
  • pH 7.35–7.45
  • PaCO₂ 35–45 mmHg
  • HCO₃⁻ 22–26 mEq/L
  • PaO₂ 80–100 mmHg

Labs — new for Exam 2

  • BUN 10–20 mg/dL
  • Creatinine 0.6–1.2 mg/dL
  • BUN:Cr — prerenal >20:1
  • eGFR — ESRD <15
  • Phosphorus 2.5–4.5 mg/dL
  • Troponin <0.04 ng/mL
  • BNP <100 pg/mL
  • Platelets 150–450 k
  • INR therapeutic 2–3
  • aPTT therapeutic 1.5–2.5×
  • Digoxin 0.5–2.0 ng/mL
  • Phenytoin 10–20 mcg/mL
  • Ammonia 15–45 mcg/dL
  • Lipase 0–160 U/L

Acid–base by source

  • Diarrhea / lower GI ACIDOSIS
  • Vomiting / NG suction ALKALOSIS
  • AKI & CKD ACIDOSIS
  • Loop / thiazide alkalosis
  • Neuromuscular resp. failure RESP. ACIDOSIS
  • Refeeding ↓phos ↓K ↓Mg

Hyperkalemia — the order

  • 1 · Stabilize calcium gluconate
  • 2 · Shift in insulin + dextrose
  • 3 · Remove binder / loop / dialysis
  • ECG first change peaked T waves

See first — priority red flags

  • Rigid board-like abdomen, lies still = peritonitis
  • Sudden relief of appendix pain = rupture
  • Silent abdomen after hyperactive = ischemia
  • Dusky or black stoma = notify surgeon now
  • Hematemesis in a cirrhotic = varices, airway first
  • Any transfusion reaction = stop, NS, new tubing, notify
  • Nitrate + PDE-5 inhibitor = withhold
  • Apical HR <60 with digoxin = hold
  • Pink frothy sputum = sit up, O₂, loop diuretic
  • Platelet drop day 5–10 on heparin = HIT, stop all heparin
  • K⁺ 6+ with peaked T waves = calcium gluconate first
  • Absent thrill or bruit = clotted fistula
  • Cloudy PD effluent = peritonitis
  • Post-TURP ↓Na⁺ + confusion = TURP syndrome
  • Obstructing stone + fever = urologic emergency
  • New confusion in an older adult = delirium, find the cause
  • Thunderclap headache = subarachnoid hemorrhage
  • Widening pulse pressure + bradycardia = Cushing's triad
  • SLUDGE in a myasthenic = cholinergic crisis, atropine
  • Ascending or descending weakness = check vital capacity, not SpO₂
  • Seizure ≥5 minutes = status; ABC then benzodiazepine
  • Phenytoin + dextrose = never; normal saline only
  • Rash on lamotrigine = stop, Stevens–Johnson
  • Fixed mid-dilated pupil, hard red eye = acute angle closure
  • Flashes, floaters, curtain = retinal detachment
  • Tinnitus on gentamicin or furosemide = early ototoxicity
  • 9/10 pain with normal vitals = believe it and treat it

Drug collisions

  • PDE-5 + nitrate — refractory hypotension
  • ACEi + ARNI — angioedema, 36-h washout
  • ACEi/ARB + MRA + salt sub — hyperkalemia
  • Digoxin + loop — hypokalemia → toxicity
  • Aminoglycoside + loop — oto- + nephrotoxic
  • Enzyme-inducing AED + OCP — contraceptive failure
  • Valproate + lamotrigine — SJS risk
  • Aminoglycoside in myasthenia — precipitates crisis
  • Anticholinergic + narrow angles — acute glaucoma
  • Anticholinergic in an older adult — delirium, retention, constipation
  • NSAID in CKD — AKI
  • Triptan in CAD — vasospasm
  • Metformin + contrast — hold 48 h

Positioning

  • Arterial / PAD DANGLE
  • Venous / DVT ELEVATE
  • Pulmonary edema high Fowler's
  • Peritonitis semi-Fowler's, knees flexed
  • Pancreatitis lean forward
  • Tube feeding HOB 30–45°
  • Seizure side-lying
  • ↑ICP HOB 30°, head midline
  • Post-cataract unoperated side
  • Gas bubble in eye face-down, no flying
Provenance

How this was built

Sourcing, gap logic, guideline verification, and one stated limitation.

Mechanics & references

How this guide was constructed, and why it is shaped the way it is.

Source handling. Your two files were parsed rather than read — the HTML was tag-stripped in Python to separate rendered content from styling, then its embedded script block was read separately to recover the flashcard array and phase-plan objects, which is where the exam date and six-week schedule actually lived. Everything clinically sound in both files was preserved verbatim or near-verbatim; the tables you already know were not rewritten, because re-encoding familiar material in unfamiliar wording during a five-day window creates interference rather than depth.

Gap identification. Coverage was computed as a set difference: standard NCLEX-RN test-plan content for each of the six body systems, minus what your files demonstrably contained. Results were then ranked by expected point loss rather than topic count — which is why acute coronary syndrome and acute kidney injury were written at full length while irritable bowel syndrome received a paragraph, despite the latter category containing more discrete topics. A gap in a high-frequency, high-acuity domain costs more than several gaps in low-frequency ones.

Guideline verification was targeted, not exhaustive. Searches were run only where your files make a specific falsifiable claim that guidelines have plausibly moved past, and where I was authoring content fresh. That produced one substantive correction — the H. pylori regimen — and confirmed that your hypertension categories and heart-failure pillars are current. The H. pylori case is presented as both regimens deliberately: item banks lag guideline publication by years, so the exam-correct answer and the practice-correct answer can diverge, and the useful skill is knowing which is which rather than which is "right."

Why the + NEW tagging exists. Your files are a condensed working layer, not the full unit architectures, so I cannot distinguish "out of scope" from "not condensed." Tagging transfers that triage decision to you at negligible reading cost. Under-inclusion costs points on Sunday; over-inclusion costs a few minutes of scanning this week. The asymmetry favors including it.

Why the cross-system section exists at all. Exam 1 tested four units sharing one substrate. Six units that interact produce a qualitatively different item type — the cross-system stem — which is not learnable by studying units sequentially. Part 4 exists because the chains in §4.5 are the actual construction template for cumulative unfolding cases, and being able to traverse a chain from any link is a distinct skill from knowing each link.

Why the applied items include distractor logic. Reading a correct answer teaches recognition; articulating why a wrong answer is wrong teaches discrimination, which is what a four-option item actually measures. Several distractors were written to fail for specific diagnosable reasons — reversed arterial/venous positioning, anchoring on normal vital signs, treating a stabilizing agent as a lowering agent — so that a miss identifies a fixable reasoning pattern rather than a vague content gap.

Why the plan front-loads and protects sleep. New and unfamiliar material is placed Tuesday through Friday so there is still time to patch failures; consolidation and mixed retrieval are placed Saturday, when interleaving produces more durable retention than blocked practice. Sunday morning is deliberately empty: cramming immediately before an exam consumes the working memory that multi-step clinical reasoning requires, and with 200% time your constraint is cognitive stamina, not clock.

One limitation, stated plainly. This guide is built from the current NCLEX blueprint and 2024–2026 guidelines reconstructed against your two files. It will be strong on standard high-yield content and may miss course-specific quirks — an instructor's pet distinction, a textbook edition's idiosyncratic numbers, a lecture emphasis. Where this guide and your course materials disagree on a specific value or regimen, your course materials are the exam-correct answer. Note the divergence, learn both, and move on.

American College of Cardiology. (2025, October 1). High blood pressure focus of new ACC/AHA guideline. https://www.acc.org/latest-in-cardiology/articles/2025/10/01/01/new-in-clinical-guidance-hbp

American Heart Association. (2025). 2025 high blood pressure guideline: Top things to know. Professional Heart Daily. https://professional.heart.org/en/science-news/2025-high-blood-pressure-guideline/top-things-to-know

Cardi-OH. (2025). 2025 ACC/AHA guideline for high blood pressure in adults. https://www.cardi-oh.org/resources/current-57--2025-accaha-guideline-for-high-blood-pressure-in-adults

Guideline Central. (2024). ACG Helicobacter pylori infection clinical guideline summary 2024. https://www.guidelinecentral.com/guideline/13288/

Guideline Central. (2024). 2024 KDIGO chronic kidney disease clinical guidelines summary. https://www.guidelinecentral.com/guideline/25092/

Guideline Central. (2026, February). New 2026 AHA/ASA acute ischemic stroke guideline update. https://www.guidelinecentral.com/insights/feb-2026-ahaasa-earlymanagementacuteischemicstroke-guideline-spotlight/

Kidney Disease: Improving Global Outcomes. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: Executive summary. https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf

Prabhakaran, S., Gonzalez, N. R., Zachrison, K. S., et al. (2026). 2026 guideline for the early management of patients with acute ischemic stroke: A guideline from the American Heart Association/American Stroke Association. Stroke. https://www.ahajournals.org/doi/10.1161/STR.0000000000000513

TCTMD. (2025, October 3). ACC updates HFrEF decision pathway, reinforcing the four pillars of therapy. https://www.tctmd.com/news/acc-updates-hfref-decision-pathway-reinforcing-four-pillars-therapy

University of Illinois Chicago Drug Information Group. (2025, January). What are the latest guideline recommendations for the treatment of Helicobacter pylori infection in the U.S.? https://dig.pharmacy.uic.edu/faqs/2025-2/january-2025-faqs/

University of Minnesota College of Pharmacy. (2024). 2024 American College of Gastroenterology H. pylori guidelines. https://www.pharmacy.umn.edu/2024-american-college-gastroenterology-h-pylori-guidelines

U.S. Pharmacist. (2025, December 12). Updated guidance on diagnosing and treating Helicobacter pylori infection. https://www.uspharmacist.com/article/updated-guidance-on-diagnosing-and-treating-helicobacter-pylori-infection